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ABSTRACT 
 
Tiwari, Sarika. M. S., Purdue University, August 2013. Expression of Histone 
Deacetylase Enzymes in Murine and Chick Optic Nerve. Major Professor: Teri 
Belecky-Adams. 
  
Epigenetic alterations have been shown to control cell type specification and 
differentiation leading to the changes in chromatin structure and organization 
of many genes. HDACs have been well documented to play an important role 
in both neurogenesis and gliogenesis in ganglionic eminence and cortex-
derived cultures. However, the role of HDACs in glial cell type specification 
and differentiation in the optic nerve has not been well described. As a first 
step towards understanding their role in glial cell type specification, we have 
examined histone acetylation and methylation levels as well as the 
expression levels and patterns of the classical HDACs in both murine and 
chick optic nerve. Analysis of mRNA and protein levels in the developing optic 
nerve indicated that all 11 members of the classical HDAC family were 
expressed, with a majority declining in expression as development proceeded. 
Based on the localization pattern in both chick and murine optic nerve glial 
cells, we were able to group the classical HDACs: predominantly nuclear, 
nuclear and cytoplasmic, predominantly cytoplasmic. Nuclear expression of
xiii 
 
 
 HDACs during different stages of development studied in this project in 
bothmurine and chick optic nerve glial cells suggests that HDACs play a role 
in stage-dependent changes in gene expression that accompany 
differentiation of astrocytes and oligodendrocytes. Examination of localization 
pattern of the HDACs is the first step towards identifying the specific HDACs 
involved directly in specification and differentiation of glia in optic nerve.  
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CHAPTER 1. INTRODUCTION 
 
1.1 Background 
Epigenetics is the study of various alterations that regulate the transcriptional 
activity of genes without changing the nucleotide sequence on DNA (Holliday 
2006). Histones proteins can be modified in different ways; acetylation/ 
deacetylation, methylation, phosphorylation, ubiquituination and somoylation. 
Study of these epigenetic modifications has been an area of interest because of 
their implication in both development and disease processes, such as cancers, 
neurological disorders and diabetes (Egger, Liang et al. 2004; Peterson and 
Laniel 2004; Esteller 2008). Environmental factors such as stress, nutrition and 
heavy metal exposures have also been documented to induce histone 
modifications that can subsequently alter gene expression (Wade and Archer 
2006). 
 
Modification of histones by histone deacetylase enzymes (HDACs) has been 
described to play an important role in glial cell development in central nervous 
system in general (Hsieh and Gage 2004). The role of these modifications in 
ocular disorders has been an area of interest over the past decade (Cvekl and 
Mitton 2010). However, there is very little is known of their role in differentiation
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of astrocytes and oligodendrocytes within the optic nerve. The focus of this study 
was to begin to determine the epigenetic state of optic nerve glia by studying 
histone modifications and histone modifying enzymes during the development of 
the optic nerve. Understanding the normal epigenetic state of the optic nerve in 
development will lay the groundwork for understanding potential role in disease 
processes such as diabetes and glaucoma. 
  
The portion of this text describing the expression patterns of the classical HDACs 
in both murine and chick optic nerve is prefaced by an introduction to glial cells in 
the central nervous system and optic nerve. Understanding the concept of 
epigenetic modifications and their role in transcription of genes will further help to 
correlate our findings with the differentiation process of the glial cells within the 
optic nerve. 
 
1.2 Cells in the central nervous system 
The cells in the mature central nervous system have been broadly grouped as 
the neurons and the glial cells (Fig.1) (Bergmann, Lane et al. 2006). The 
progenitor cells of the nervous system give rise to various populations of cells at 
specific but overlapping time points, starting with the generation of neurons, then 
astrocytes, and finally oligodendrocytes. During the embryonic development of 
the cortex, the neuroepithelial cells lining the ventricular and the sub-ventricular 
zone give rise to the radial glial cells. Through the process of neurogenesis these 
radial glial cells give rise to two different type of cells; neurons and glial precursor 
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cells (Gage 2000; Temple 2001). Based on the extrinsic and intrinsic signals, 
glial precursors further differentiate into the various types of the glial cells. 
Glial cells are further categorized as macroglia and microglia. Macroglia are 
further subdivided into astrocytes, oligodendrocytes and ependymal cells 
each of which have their own functions to be covered in the next sections 
(Ridet, Malhotra et al. 1997; Qian, Shen et al. 2000; Okano 2002; Zawadzka, 
Rivers et al. 2010).  
 
1.3 Glial cells of the nervous system 
 
1.3.1 Microglia cells 
Commonly known as the scavenger cells of the central nervous system, 
microglia help to protect against the microbial organisms. They play an 
important role in removing the dead tissue fragments and provide support to 
the neurons. They have been classified into different types based on their 
reactivity to inflammatory signals (Cameron and Rakic 1991; Hurley, Walter et 
al. 1999; Grossmann, Stence et al. 2002; Czeh, Gressens et al. 2011).  
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1.3.2 Macroglial cells 
 
1.3.2.1 Ependymal cells 
Ependymal cells line the ventricles and the central canal of the spinal cord 
(Morest and Silver 2003). Their main function is secretion, movement, and 
recycling of cerebrospinal fluid (CSF) into the ventricles of the brain and 
creation of the brain-CSF barrier. CSF is secreted from a structure called the 
choroid plexus; a network of blood vessels lined with ependymal cells that is 
located in all the four ventricles of the brain. The tight junctions of the 
ependymal cells lining the vessels thereby help in the formation of CSF 
through the filtration of the blood from the capillaries (Serot, Zmudka et al. 
2012). In addition to secretion and movement of CSF, the cells also act as a 
filter for some chemicals such as neurotransmitters (NT’s). Improper 
functioning of the ependymal cells leads to the development of hydrocephaly 
due to abnormality in the clearing of the cerebrospinal fluid (Rothfus and 
Latchaw 1985; Taulman, Haycraft et al. 2001; Jacquet, Salinas-Mondragon et 
al. 2009; Del Bigio 2010). Ependymal cells have also been documented to act 
as a stem cell under certain situations (Carlen, Meletis et al. 2009). 
 
1.3.2.2 Oligodendrocytes 
Oligodendrocytes are the other type of macroglial besides ependymal cells 
and astrocytes, widely studied in the central nervous system. They are the 
myelinating cells of the central nervous system. Insulation of axons by myelin 
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sheath provides an increase in the speed of the neuronal conduction, 
nutritional support to the axons, and maintains neuronal growth and survival 
(Weatherby, Davis et al. 2000). Defective myelination of the central nervous 
system has been known to be associated with various demyelinating 
diseases such as multiple sclerosis where focal loss of myelination leads to 
severe functional deficits (Bunge 1968; Waxman 1992; Furusho, Dupree et 
al. 2012; Soldan and Pirko 2012). 
  
1.3.2.3 Astrocytes 
Astrocytes are well known as one of the major macroglial cell types of the 
central nervous system. These glial cells originally thought to be inert but 
have now been shown to be dynamic and interactive (Butt, Pugh et al. 
2004). (Sofroniew, Vinters et al. 2010). Their functions include: 1) providing 
extracellular matrix proteins and adhesion molecules, which help to develop 
and maintain structural integrity of the central nervous system, 2) providing 
trophic support to neurons and neurite promoting factors in the form of 
soluble and substrate bound factors, 3) serving as an energy reserve by 
storing glycogen, and supplying energy to glucose deprived neurons, 4) 
aiding in the formation of tight junctions between endothelial cells that form 
the blood brain barrier (BBB), and providing structural support and help in 
transport of materials across the BBB, 5) maintaining homeostasis within the 
nervous system by taking up molecules such as ATP, glutamate, glycine and 
regulating extracellular ion concentration and maintaining pH and osmolarity, 
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6) metabolizing neurotransmitters and heavy metals and thus prevent these 
molecules from reaching toxic levels in the environment and 7) assistance in 
development of neuronal synapses during nervous system development 
(Montgomery 1994; Freeman 2010). 
 
1.4 Classification of the astrocytes 
Astrocytes like oligodendrocytes are widely studied glial cell types. Unlike other 
glial cells their classification has been also studied in great detail. Astrocytes are 
broadly classified into fibrous and protoplasmic astrocytes based on the 
differences in their morphology and their distribution (Levison, Hudgins et al. 
1998; Sofroniew and Vinters 2010). Fibrous astrocytes are the star-shaped 
cells with relatively fewer intracellular organelles found mainly in the white 
matter of the CNS. The long unbranched processes are symmetrically 
distributed on their cell surface and have abundant intermediate filaments. 
Protoplasmic astrocytes, on the other hand, have a more complex morphology. 
Their processes are branched with fewer intermediate filaments as compared to 
fibrous types. These cells are localized to the grey matter have spherical to 
oval nuclei, and their intracellular organelles have been reported to be less in 
numbers compared to the fibrous astrocytes (Miller and Raff 1984; Sofroniew 
and Vinters 2010; Liu, Wang et al. 2012; Tsai, Li et al. 2012). 
 
Astrocytes have also been classified as type I and type II astrocytes. 
(Montgomery 1994). The type 1 astrocytes have been shown to be larger in size 
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with fewer processes as compared to the type 2 astrocytes. While both these 
type of astrocytes express glial fibrillary acidic protein (GFAP), type 2 astrocytes 
are also express A2B5 (an extracellular ganglioside) (Raff, Abney et al. 1983; 
Suarez and Raff 1989; Albrecht, Enterline et al. 2007; Rompani and Cepko 
2010). Based on their anatomical features and regional distribution, there has 
been some correlation found between the two classifications; type 1 astrocytes 
have been found to have some similarity to protoplasmic astrocytes whereas 
type 2 astrocytes have been shown to resemble fibrous astrocytes (Raff, Miller et 
al. 1983). 
 
1.5 Molecular signals responsible for specification of oligodendrocytes and 
astrocytes 
As mentioned earlier neuronal stem cells, also known as neural precursors 
can become neurons or glial cells in the central nervous system depending on 
the molecular signals they receive. These signals such as sonic hedgehog 
(SHH) and fibroblast growth factor (FGF) have been identified to play role in 
the specification of oligodendrocytes (Chandran, Kato et al. 2003; Fogarty, 
Richardson et al. 2005). The role of bone morphogenetic proteins (BMPs), 
SHH, ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF) in 
restricting the lineage specification of the multipotent neural precursors 
towards astrocytes has been also well established (Fig.5) (Kessaris, Pringle et 
al. 2008; Agius, Decker et al. 2010; Rowitch and Kriegstein 2010).  
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Understanding of these signaling pathways has helped to elaborate the role of 
various transcription factors/protein complexes in regulation of transcription of 
genes (Turner 2002; Kouzarides 2007). Role of post-translational modifications 
on to the promoter of the target genes through histone modifying enzymes will 
help to provide more insight into the process as described in later sections. A 
more detailed view of common pathways involved in the specification of 
astrocytes below will aid in understanding the interplay between the signaling 
pathways and epigenetic modifications described in subsequent sections. 
 
1.5.1 CNTF and LIF signaling pathway 
Both CNTF and the LIF belong to the family of GP130 family of cytokines 
(Taga and Kishimoto 1997). LIF specifically belongs to the IL6 family of 
cytokines (Aghajanova, Skottman et al. 2006). LIF is known to play an 
important role in the proliferation and differentiation of the embryonic stem 
cells (Niwa, Burdon et al. 1998). CNTF and LIF initiate signaling upon binding 
to their receptors, the CNTFRα and LIFβ then recruit the co-receptor GP130 
to form heterodimers leading to the phosphorylation and activation of the 
Janus kinase (JAKs) (Fig.2). Activated JAKs phosphorylate the transcription 
factor, signal transducer and activator of transcription 3 (Stat3). Activated 
Stat3, on dimerization, is translocated to the nucleus where it recruits the 
histone acetyl transferase (HAT) p300 to one of the binding sites on the 
GFAP promoter. The GFAP gene is one of the many astrocyte-specific genes 
critical for the proper differentiation of astrocytes (Darnell 1997; Levy and 
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Darnell 2002). Acetylation of histones on promoter has been shown to create 
changes to the chromatin structure there by providing access to the 
transcriptional machinery (transcriptional factors and non-histone protein co-
activators) (Turner 2002; Kouzarides 2007). This further leads to the transcription 
initiation of target genes, astrocytic genes here as discussed in later sections. 
 
1.5.2 BMP pathway (Bone morphogenetic proteins) 
The BMPs belong to the transforming growth factor-β (TGFβ) family. They 
mediate their effect through type I and type II receptors which are members of 
serine threonine kinase family of proteins. Upon ligand binding, type 1 and type 
2 receptor dimerize followed by tetramerization. The type 1 receptor then 
phosphorylates and activates the downstream signaling components, SMAD1, 5, 
and 8. The activated SMAD then bind to the co-SMAD (SMAD4) and the dimer is 
translocated to the nucleus where they cooperatively regulate gene expression 
with other transcription factors. Within astrocytes, SMADs, STAT3 and p300, 
cooperatively interact to upregulate the GFAP expression in astrocytes (Fig.2) 
(Ten Dijke, Goumans et al. 2002; Miyazono, Maeda et al. 2005; Kessaris, Pringle 
et al. 2008). Hence, both these pathways have at least one common meeting 
point, the GFAP promoter where they both bring in a HAT and activate the 
transcription of the genes for astrocytes. Both these pathways act parallel and in 
combination with one another to activate transcription factors and recruit co-
activators that provide access to the GFAP promoter. Hence, the role of histone 
modifying enzymes (histone acetyl transferases and histone deacetylases) 
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during the transcriptional activation of astrocytic genes is crucial (Mabie, Mehler 
et al. 1999; Nakashima, Yanagisawa et al. 1999; Robel, Berninger et al. 2011). 
 
1.5.3 Sonic hedgehog (SHH) 
SHH belongs to the family of the hedgehog proteins and is known to play an 
important role in the patterning of the CNS, and in differentiation and 
proliferation of oligodendrocytes (Nery, Wichterle et al. 2001; Marti and 
Bovolenta 2002). There have been some reports that show SHH contributing 
to the development and proliferation of astrocytes as well (Garcia, Petrova 
et al. 2010). SHH has been documented through cortical cell culture studies 
to directly support the development of astrocytic precursors (Cahoy, Emery 
et al. 2008). Studies have also described the significance of SHH from retinal 
ganglion cells in development of optic disc and optic stalk neuroepithelial cells 
(Dakubo, Wang et al. 2003). Further SHH signaling from the retinal ganglion 
cells has been shown to stimulate the proliferation of both astrocytes and 
oligodendrocytes in the optic nerve (Wallace and Raff 1999). Previous work 
from our lab has shown that cooperation between the SHH and BMP7 
pathway increases transcription of the pax2 gene in type I astroyctes of the 
optic nerve by interfering with the binding of a transcriptional repressor, TLX, 
(Sehgal, Sheibani et al. 2009). 
 
In vertebrates, the SHH signaling pathway is initiated by binding of SHH to 
the transmembrane receptor, patched (PTC). In the absence of SHH, PTC 
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inhibits smoothened (SMO), a seven transmembrane protein. This results in 
phosphorylation and modification of the Glioma (GLI) associated factors, zinc 
finger family of transcription factors, GLI2 and GLI3 by protein kinase 
A.(PKA) (Varas, Hager-Theodorides et al. 2003). Phosphorylated forms of 
these two are proteolytically cleaved to give rise to their repressor forms. On 
the other hand, SHH binding to PTC receptor releases the inhibition on SMO. 
PKA no longer phosphorylates GLI2 and hence it does not get converted to 
its repressor form, instead serves as an activator of transcription. Besides 
PKA other kinases, glycogen synthase kinase 3 β (GSK3β) and casein 
kinase, are also involved in this process of phosphorylation (Rubin and de 
Sauvage 2006). GLI1 have been shown to acts as a transcriptional activator 
only, whereas, GLI2 and 3 have been described to be modified as repressors 
or activators. Accumulation of GLI within the nucleus of the cells is further 
regulated by a multiprotein complex formed by suppressor of fused [Su (Fu)] 
which serves as an inhibitor of SHH signaling pathway (Fig.3) (Marti and 
Bovolenta 2002; Crompton, Outram et al. 2007). Studies showing increase in 
the level of GLI1 on application of SHH and knock down of the intermediate 
factors in the signaling pathway have suggested its role in changes to the 
development and proliferation of the astrocytes (Garcia, Petrova et al. 2010).  
 
Hence, the CNTF, BMP, and SHH pathways have all been shown to play a 
role in lineage specification of neural precursors towards glial cells. 
Generation of mature and fully differentiated glial cells is a multistep process. 
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Many intermediate precursors have been identified to be formed during the 
process of differentiation (Rao 2004). For both oligodendrocytes and 
astrocytes a step wise process of differentiation has been identified as 
described in the next section. 
 
1.6 Differentiation of astrocytes and oligodendrocytes 
Precursor, immature perinatal and mature types astrocytes have been well 
established as shown in Fig.4 (Chu Hughesetal et al. 2001). These different 
stages can be distinguished from one another based on the proteins they 
express, their ability to further differentiate and their response to the growth 
factors. For example astrocyte precursor cells are identified by positive labeling 
for the A2B5 + and PAX2 +. Mature and well differentiated astrocytes are on the 
other hand identified by their expression of markers such as GFAP. Similarly 
different stages of differentiation have been identified for oligodendrocytes as 
well as shown in Fig.5 (Jackman 2000). Markers that help to identify these 
differentiating stages have also been identified. Oligodendrocyte precursor cells 
have been shown to express two specific markers, NG2, an integral membrane 
chondroitin sulfate proteoglycan and platelet derived growth factor receptor α 
(PDGFRα) (Rao and Mayer-Proschel 1997; Liu and Rao 2004). 
   
Optic nerve, being a part of central nervous system, has always been an area of 
interest for studies related to glial cells; oligodendrocytes and astrocytes. 
Understanding the development of the optic nerve and various glial cell types 
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present has provided a platform to researchers for further exploring the 
mechanism involved in their differentiation and compare it with the one in the rest 
of the central nervous system. The development of the optic nerve and subtypes 
of glial cells present in the optic nerve will be explained in the next sections.  
 
1.7 Development of the optic nerve 
Literature has detailed explanation about how the development of the optic nerve 
takes place as described further Development of the eye has been described to 
begin from a single layer of neuroepithelial cells, called the eye field that lies in 
the center of the rostral part of the neural plate. This region has been 
documented to begin expressing molecules like PAX6, RX1, SIX3, LHX2, and 
many others which heralds the earliest stages of eye development (Zuber, Gestri 
et al. 2003; Lamb, Collin et al. 2007). As the neural tube is formed through the 
upward and inward folding of the neural plate the eye field is shown to be 
bisected into two optic grooves that lie to either side of the midline. As 
development proceeds the optic grooves continue to enlarge and evaginate, 
eventually forming the optic vesicles (Fig.6) (Lamb, Collin et al. 2007). The 
optic vesicles come into close proximity to a thickened region of the head 
ectoderm, called the lens placode, helping to initiate the development of the 
lens vesicle. The lens placode reciprocates by sending secreted signals 
fibroblast growth factors (FGFs) which interact with the optic vesicles, 
specifying the region that will give rise to the retina in the developing optic 
vesicles (Huang, Rajagopal et al. 2011). The optic vesicles invaginate to give 
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rise to a double layered optic cup. Out of this bilayered structure the inner 
layer becomes the neural retina while the outer layer is transformed into the 
retinal pigment epithelium (RPE) (Chow and Lang 2001). The invagination of 
the optic vesicles starts from the ventral side of the optic vesicle and 
proceeds dorsally such that a fissure forms in the ventral optic cup (Fig.7) 
(Lamb, Collin et al. 2007). This fissure, known as the choroidal fissure, 
eventually closes as the cells of the ventral optic cup proliferate and migrate 
into the area (Onwochei, Simon et al. 2000). It is the optic stalk through 
which the retinal ganglion cells axons exit the eye (Lamb, Collin et al. 2007). 
In the next section, the major types of glial cells in the optic nerve, 
oligodendrocytes, type I and type II astrocytes, will be discussed. 
 
1.8 Glial cells in the optic nerve 
The glial cells present in the optic nerve include type I and type 2 astrocytes 
and oligodendrocytes. Both mature type 1 and type 2 astrocytes are positive 
for the glial fibrillary intermediate filament (GFAP). Differences between the 
two types of astrocytes are; 1) type 1 astrocytes in the optic nerve are rat 
neural antigen 2 (Ran2) + and A2B5 - and type 2 astrocytes are Ran2 - and 
A2B5 +, 2) type 1astrocytes can be induce to proliferate in culture in the 
presence of the epidermal growth factors (EGF) and glial growth factors 
(GGF) unlike type 2 (Raff, Abney et al. 1983; Suarez and Raff 1989; (Lemke and 
Brockes 1984; Barres, Chun et al. 1989). 
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Like most cells, both the oligodendrocytes and astrocytes that populate the 
optic stalk/nerve have been shown to undergo a step-wise process in their 
differentiation (Rao et al. 2004). The type I astrocytes in the optic nerve 
originate from the neuroepithelial precursor cells (NEP) that comprise the 
optic stalk (Small, Riddle et al. 1987). These cells proliferate and give rise to 
a population of cells referred to as astrocyte precursor cells that appear 
producing astrocytes. Another group of progenitor cells, referred to as O2A 
progenitors, migrates from the lateral and medial ganglionic eminences of the 
diencephalon into the optic nerve, where they continue to proliferate and give 
rise to oligodendrocytes (Jackman, Ishii et al. 2009). When placed in vitro, 
these O2A progenitors can also give rise to type II astrocytes. There are 
conflicting reports in the literature as to whether O2A progenitors are capable 
of producing both astrocytes and oligodendrocytes in vivo (Levison and 
Goldman 1993; Rao 1999). Finally, results from Rompani and Cepko (2010) 
have shown a glial restricted progenitor from which both oligodendrocytes 
and astrocytes can be generated (Liu and Rao 2004; Kim, Park et al. 2006; 
Menn, Garcia-Verdugo et al. 2006; Rivers, Young et al. 2008; Zhu, Bergles et 
al. 2008; Jackman, Ishii et al. 2009). Retina also contains astrocytes, one of the 
three macroglail cells as described earlier and therefore an introduction to retina 
and its cell types including the müller glial cells will be discussed in the next 
section.  
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1.9 Mature retina and its cell types 
The mature retina is made up of seven different layers: 1) retinal pigment 
epithelium (RPE) made up of the cuboidal cells forming the outermost layer, 2) 
the outer nuclear layer contains the cell bodies of the light transducing 
photoreceptors, 3) the outer plexiform layer is composed of synapses between 
the photoreceptors and the bipolar and horizontal cells, 4) the inner nuclear 
layer contains the bipolar cells and the inhibitory amacrine and horizontal cells, 
in addition to the Müller glial cells, 5) the inner plexiform layer comprised of 
synapses between the bipolar cells (inner nuclear layer) and the ganglion cells  
(ganglion cell layer), 6) the ganglion cell layer contains the ganglion cells and 
displaced amacrine cells and finally 7) the nerve fiber layer includes the fibers 
from the ganglion cells that leave the eye through the optic nerve and retinal 
astrocytes (Fig.8) (Adler 2000; Doh Hao et al. 2010). The three major types of 
glial cells in the retina are; the Müller glial cells, the retinal astrocytes and the 
microglia. Some species also have oligodendrocytes in the nerve fiber layer of 
the retina; however oligodendrocytes are not found in large majority of retinas 
(Czekaj, Haas et al. 2012). Müller glial processes span the entire width of the 
retina, comprising the outer limiting membrane near the photoreceptor cell 
bodies and the inner limiting membrane that forms the boundary between the 
retina and the vitreous. They arise from a common multipotent retinal 
progenitor that gives rise to both neuronal cell types as well as the Müller glial 
cells at different time points during the differentiation process. Retinal 
astrocytes do not originate within the retina but migrate in from the developing 
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optic nerve. Microglial cells arise from the mesenchymal cells outside the eye 
and migrate into the eye with the endothelial cells that will comprise the retinal 
vasculature eventually (Fletcher, Downie et al. 2010; Ma, Zhao et al. 2012; 
Nelson and Hyde 2012; Provis 2001). 
 
Studies using genome wide profiling have shown an association between glial 
cell type lineage specification, differentiation and epigenetic regulation of the 
target genes with in telencephalon (Hatada, Namihira et al. 2008). Similarly 
results have also established role of epigenetic regulation in both neurogenesis 
and gliogenesis in central nervous system in general (Juliandi, Abematsu et al. 
2010). However, the role of epigenetic regulation within the optic nerve is not 
understood. 
  
1.10 Epigenetics 
Epigenetics is defined as the “study of the heritable changes in gene 
expression that are not due to changes in DNA sequence” (Wolffe and 
Matzke 1999). Epigenetic alterations within the DNA and or the histone 
proteins in a cell have been shown to play a crucial role during the 
development and differentiation (Sharma, Kelly et al. 2010; Wang, Sorensen 
et al. 2012). Differentiation of cells is induced by the epigenetic changes in 
the chromatin and nuclear proteins within the nucleus of the multipotent stem 
cells as well as the intermediate progenitors (Schubeler, Francastel et al. 
2000). 
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1.11 Chromatin and the histones 
Chromatin, the nucleoprotein made of a histone octamer and DNA. Histones 
have been basically classified into five different families of proteins; H2A, 
H2B, H3 and H4 that form the core of the histone octamer and the linker 
histones, H1 and H5 that help to provide a higher order structure to the 
chromatin packaging. All these histones together with the 147 base pairs of 
DNA wrapped around the histones form the nucleosome (Fig.9) (Caterino and 
Hayes 2007). Chromatin has been divided into two main groups according to 
packaging and structural detail; 1) Euchromatin is the more loosely packaged 
DNA in the nucleus that represents genes that are actively being transcribed 
and 2) Heterochromatin is the more compact form of the nucleosome that 
represents genes that are not being actively transcribed (Fierz and Muir 
2012). 
 
Epigenetic alterations and or modifications of these histone proteins are 
responsible for bringing in changes to the organization of chromatin, thereby 
providing or restricting access of the transcription factors to cis-acting 
elements of target genes. There are several different ways identified in which 
histones can be modified.  
 
1.12 Modifications of the histones 
Post translational modifications of histones have been documented to be 
strongly influencing the transcription of several genes in eukaryotes. Of these 
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different types of modifications, methylation, phosphorylation, ubiquitylation 
and sumoylation, as well as ribosylation are the examples (Peterson and 
Laniel 2004). Histone modifications are likely to bring about distinct functional 
consequences to the chromatin. Histone modifications have been described 
to be associated with changes in the transcriptional activity of the genes. For 
example acetylation of H3K14 and H4K8 and phosphorylation at H3S10 
position are all associated with transcriptional activation, while methylation at 
H3K9 and H3K27 are associated with transcriptional repression under most 
circumstances (Peterson and Laniel 2004; Fuks 2005). 
 
The term ‘histone code’ refers to a particular combination of histone 
marks/modifications which, unlike the genetic code, may have different 
meaning depending on the context. For example, TAG always means STOP 
transcription as far as the gene code is concerned. However, in regard to the 
histone code/modifications methylation or acetylation of the lysine or arginine 
side chains of histones at the same position can act as a transcriptional 
activator or repressor under different situations depending on the gene 
(Jenuwein and Allis 2001; Agalioti, Chen et al. 2002; Turner 2002; Lachner, 
O'Sullivan et al. 2003; Peterson and Laniel 2004). 
 
1.12.1 Histone acetylation 
Histone acetylation is the reversible alteration at the N-terminus of a lysine 
rich histone that is controlled by the histone acetyltransferases (HATs) and 
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the histone deacetylases (HDACs) families of enzymes. Acetylation of these 
lysine residues leads to the conversion of the amine group into amides, 
thereby leading to the loss of the net positive charge on the histone tails that 
binds to the negatively charged phosphate group of the DNA, this loosening 
the bonds between the two forms a more open conformation of the DNA 
(Fig.10) (Korzus 2010). The open conformation of the DNA allows other 
transcription factors and transcriptional machinery access to the sites they 
must bind to in order to affect transcription. HDACs remove acetyl group from 
histone tails, generally resulting in chromatin condensation and an overall 
repression of transcription. While HATs, add an acetyl group to histone tail 
leading to open chromatin structure and increased transcriptional activity. The 
balance between the actions of these enzymes serves as a key regulatory 
mechanism for gene expression and therefore plays an important role in the 
cell type specification, differentiation and de-differentiation.  
 
Although HDACs generally are thought of as being important for 
transcriptional repression, recent evidence suggests that they can also be 
involved in activation. The cell types that are derived from the stem cells of 
the nervous system are in part based on the epigenetic mechanisms leading 
to the reorganization of chromatin structure (Marks, Miller et al. 2003; 
Shabbeer and Carducci 2005; Wu and Sun 2006; Kiefer 2007; Sharma, 
Tomar et al. 2007; Korzus 2010). 
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The HDAC superfamily, based on sequence similarities has been divided into 
the following four classes; 1) Class 1 includes HDAC1, 2, 3, and 8, 2) Class 2 
i s  further subdivided as Class 2a and 2b has HDAC4 through 7, 9, and 10 
under, 3) NAD-dependent,Sir2-like deacetylases named sirtuins fall under this 
class and 4) Class 4 has HDAC11 (Fig.11) (Gray and Ekstrom 2001; Khochbin, 
Verdel et al. 2001; Kao, Lee et al. 2002; Kyrylenko, Kyrylenko et al. 2003; 
Gregoretti, Lee et al. 2004; Yang and Seto 2008), (See Fig.9) (Gao, Cueto 
et al. 2002; Ververis and Karagiannis 2012). 
  
1.12.2 Histone methylation 
Histone methylation is yet another post translational modification leading to 
epigenetic changes to the chromatin structure. Histone methyl transferases 
(HMTs) and lysine specific demethylases (LSD1) regulate the reversible 
methylation at the promoter associated CpG islands. Methylation of histone 
can serve as transcriptional activator or repressor depending on the lysine 
chain involved. DNA methylation has been shown to play important role in cell 
type specification and differentiation of glial cells (Kohyama, Kojima et al. 
2008). Studies using HDAC inhibitors have shown the role of HDACS in 
regulating methylation marks (Sarkar, Abujamra et al. 2011). Hence HDACs do 
seem to help in histone methylation indirectly. 
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1.13 Histone modifications and transcription of genes 
Gene regulation has been shown to be dependent on transcription factors and 
chromatin packaging. Transcriptional unit in eukaryotes is made up of enhancer, 
core promoter, also known as the transcription start site and initiator element. It 
is the core promoter that serves as the recruiting site for complex transcriptional 
machinery including several transcriptional factors (TFs), TFll D, TFllB and TFllA, 
transcription binding proteins (TBP) and RNA polymerase ll (RNA Pol ll) (Fig.12) 
(Fischle, Wang et al. 2003; Levine and Tjian 2003; Sekine, Tagami et al. 2012). 
Binding of the initiation complex serves to unfold the DNA and initiate 
transcription of the target genes. Modifications of histones cause changes to the 
chromatin structure and serve to recruit non histone complex proteins also 
known as chromatin remodeling complexes and coactivator complexes which 
further allows the binding of TFs and RNA Pol ll thereby regulating transcription 
of genes (Turner 2002; Kouzarides 2007). Studies have established that histone 
acetylation at H3K9/K14 further bring in SWItch/Sucrose nonfermentable 
(SWI/SNF) remodeling complexes along with the TFllD, transcription initiation 
factors, thereby regulating the initiation of transcription process for the target 
genes (Struhl 1998; Fukuda, Sano et al. 2006). 
 
Transcription regulation by methylation of histones at different loci is yet another 
example of involvement of multiprotein complexes during the process. For 
example methylation of histone at H3K9 leads to the recruitment of 
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heterochromatin protein 1 (HP1) and SWI6, heterochromatin associated proteins. 
These protein complexes are known to recognize the methylated histone binding 
sites through their chromodomains thereby leading to changes in the chromatin 
packaging and preventing the access to the transcriptional factors (Jenuwein and 
Allis 2001; Rice and Allis 2001; Geiman and Robertson 2002). Studies using 
segments of mouse methyl CpG binding protein 2 (MeCP2) fused to Glutathione-
S-transferase have shown role of DNA methylation and recruitment of HDAC 
complexes, mSin3A/HDAC, to the promoter of the target genes thereby leading 
to transcriptional silencing (Dobosy and Selker 2001). 
 
1.14 Role of epigenetics in glial cell development 
Cell-type specification and differentiation is controlled by epigenetic 
mechanism leading to the changes in chromatin structure and functions of 
many genes. HDACs have been well documented to play an important role in 
both neurogenesis and gliogenesis in ganglionic eminence and cortex-derived 
cultures in which HDACs were inhibited using inhibitors. Studies have also 
documented that HDACs are involved in specification and differentiation of 
oligodendrocytes (Marin-Husstege, Muggironi et al. 2002; Hsieh and Gage 
2004; Shaked, Weissmuller et al. 2008). Inhibition/knock out of HDACs have 
shown to switch the fate between oligodendrocyte precursors and neurons 
(Liu, Han et al. 2007). Most of the work in literature discusses the role of HDACs 
in differentiation of neurons and oligodendrocytes with in the central nervous 
system in general. However not much is known about their role in differentiation 
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of glial cells in the optic nerve. In addition to histone deacetylation, are there 
other post translational modification also involved in transcriptional regulation 
does not seem to be clear. Whether the HDAC inhibition will lead to this fate 
switch between gliogenesis and neurogenesis in the developing optic nerve 
also has not been studied in detail yet.  
 
Other investigators have hypothesized that neural stem cells and mature 
neurons maintain a state of global acetylation whereas the differentiated glial 
cells, astrocytes and oligodendrocytes, on the other hand maintain a state of 
global deacetylation (Hsieh et al. 2004). Based on our own observations we 
have put forth the following two-part working hypothesis: 1) Combinatorial 
role of specific HDACs are necessary for the differentiation of optic nerve 
astrocytes and oligodendrocytes and 2) inhibition of HDAC activity will block 
the fate of oligodendrocytes and astrocytes of the optic nerve. As a first step 
towards understanding the role of histone deacetylation in differentiation of 
astrocytes and oligodendrocytes with in the optic nerve, we examined whether 
the concept of a global state of deacetylation in differentiated cells holds true. 
Also to find answers to which of the classical HDACs are involved in the 
differentiation of glial cells, we characterized their spatial and temporal 
expression patterns in murine and chick optic nerve. These studies will lay the 
groundwork for determining which HDACs might be involved in the differentiation 
of optic nerve glia and will allow us to test the role of acetylation in glial cell 
differentiation.  
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CHAPTER 2. MATERIALS AND METHODS 
 
2.1 Animal husbandry and tissue collection 
All animals used for this study were treated according to the ARVO statement 
for animal care. C57BL/6J mice were obtained from Jackson Labs and were 
housed in the Accreditation of Laboratory Animal Care (ALAC) accredited 
animal care facility in the School of Science on a 12 hours (hrs) light/dark 
cycle. For embryonic stages, mice were mated overnight and the females 
checked for vaginal plugs the next morning. The date the vaginal plug was 
detected was designated 0.5 days post coitum. At embryonic day 16 (E16), 
heads were removed and for postnatal stages, eyes were dissected and fixed 
in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 at 4°C for 24 
hours. Following fixation, eyes were rinsed twice in 1X phosphate buffered 
saline (PBS; potassium chloride 200 mg/L, potassium phosphate 200 mg/L, 
sodium chloride 8000 mg/L, and sodium phosphate 1150 mg/L), pH 7.5 and 
placed in a graded series of sucrose in 0.1 M phosphate buffer, starting at 5% 
and ending with 20%. Eyes were frozen in a 3:1 ratio of 20% sucrose in 0.1 M 
phosphate buffer to Optimal Cutting Temperature (OCT) solution and stored 
at -80°C until sectioned. Chicken eggs were ordered from University of 
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Michigan and stored at 16°C in a biochemical oxygen demand incubator (Jeio  
tech: IL-11A). Eggs were then moved to 38°C incubator (Kuhl, Flemington, 
NJ) and allowed to develop until E5, 8, or 18 and embryos (E5, E8) and 
dissected eyes (E18) were fixed in 4% paraformaldehyde in 0.1 M phosphate 
buffer. E5 embryos were treated with 20% sucrose overnight while for E8 
embryos and dissected E18 eyes were treated with a graded series of 
sucrose solutions from 5 to 20% in 0.1 M phosphate buffer, pH 7.4. Embryos 
and eyes were frozen in a 3:1 ratio of 20% sucrose in 0.1 M phosphate buffer 
to (OCT) solution and stored at -80°C. 
 
2.2 Immunofluoroscence 
Ten micron sections were cut with a Leica CM3050 S cryostat on Superfrost 
Plus slides (Fisher Scientific, Pittsburgh, PA) and stored at -80°C until used 
for immunohistochemistry. Slides were removed from the freezer, allowed to 
warm at room temp for 30-40 min, liquid blocker (Electron Microscopy) applied 
to the regions surrounding the sections, and sections post-fixed with 4% 
paraformaldehyde for 30 min at room temperature. Slides were washed in 1X 
PBS two minutes twice, incubated with methanol for 10 min. at room 
temperature and washed with 1X PBS for two minutes twice. Antigen retrieval 
was performed by incubating sections in 1.0% SDS in 1X PBS for 5 minutes 
at room temperature. Slides were washed for 5 minutes 3X at room 
temperature, followed by treatment with 1.0% sodium boro-hydrite for two 
minutes at room temperature to reduce auto fluorescence. After removal of 
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the sodium boro-hydride, sections were blocked with blocking solution (5% 
bovine serum albumin, 10% donkey serum, 0.25% triton X-100 in 1X Hanks 
balanced salt solution) for two hours at room temperature. Following removal 
of blocking solution, primary antibodies were added in their respective 
concentrations and incubated overnight at 4°C in a humid chamber. Dilutions 
and sources of each antibody can be found in Table I. In order to assess the 
specificity, antibodies were preabsorbed with 1.0 mg/ml of peptide or protein 
specified for each type of HDAC antibody we used for 1 hr prior.and 
immunofluorescence was performed as usual. For IgG controls, sections were 
incubated with 0.5 ug of purified IgG in 1 ml of blocking solution in place of 
the primary antibody and immunofluorescence performed as usual. Slides 
were then washed the next day in 1X PBS 10 min twice at room temperature 
and were then incubated with secondary antibodies (Alexa-fluor conjugated 
secondaries (Donkey anti rabbit 549) from Invitrogen and DyLight conjugated 
secondaries (Donkey anti goat 488 and Donkey anti mouse 546) from 
Jackson ImmunoResearch) dissolved in 1X PBS in 1:800 concentration for 1 
hr in dark at room temperature. Secondary antibodies were removed by 
washing the slides in 1X PBS for 2 times 10 min each. Sections were 
mounted with Prolong gold anti fade containing DAPI. For the negative 
controls peptides corresponding to each HDAC were used to check the 
specificity of the HDACS as shown in Table 1. Immunolabeling was imaged 
using an Olympus Fluoview FV 10004 confocal microscope. 
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2.3 Real time-quantitative PCR (RT-qPCR) 
Optic nerves were isolated from mice quickly following euthanasia and 
preserved in RNA later stabilizing agent (Qiagen; Cat # 76104) at -80°C 
until ready for total RNA extraction. Total RNA was isolated using High Pure 
RNA Tissue Kit (Roche; Cat # 12033674001) and prior to cDNA synthesis, the 
quality of the RNA to be used was checked. cDNA was synthesized through 
reverse transcriptase using iScript cDNA synthesis kit (Biorad; Cat # 170-
8891). Real-time quantitative PCR reactions were performed on cDNA with 
Applied Biosystems Real Time PCR System (Model # 7300) using Power 
SYBR Green PCR Master Mix (Applied Biosystems; Cat # 4368706). The 
primer pairs used have been listed in Table 1. Efficiency of the primer sets 
was determined by the standard curve method, where efficiency, 
E= (10(- 1/ (CT2 - CT1))- 1) X100 
Microglobulin (B2M) was used as internal control for each cycle (Thal et al., 
2008). The amplified samples were also checked to confirm if the amplification 
was of the right size. The change in the gene T expression levels was done 
using the The amplified samples were also checked to confirm if the amplification 
was of the right size. The change in the gene expression was tested using the 
delta delta CT method, where CT is the crossing threshold value,  
ΔCT = CT Target gene – CT B2M and ΔΔCT = ΔCT treated – ΔCT 
control 
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2.4 Statistical analysis 
Using the unpaired t-test between the control and treated groups analyses of the 
RT-qPCR data was done statistically. SPSS software (IBM) and Excel 2010 
(Microsoft) were used for this purpose. 
 
2.5 SDS-PAGE and western analysis 
Optic nerve samples were lysed using Radio-Immunoprecipitation Assay 
(RIPA) lysis buffer (5M Nacl, 1M Tris pH 8.0, 0.5 M EDTA, 5% Triton-X 100 
supplemented with protease inhibitor cocktail (Roche; 04693116001) and 1 
mM phenylmethanesulfonylfluoride (PMSF) on ice. Tissue lysates were 
centrifuged at 14000 rpm for 20 min at 4°C and supernatant was collected. 
Total protein concentration was determined using bicinchoninic acid assay 
(BCA) protein Assay reagent (Thermo Scientific). Proteins were resolved 
using SDS-PAGE (4-20% gradient gel), transferred to polyvinylidene 
difluoride (PVDF) membranes and immunoblotted using HDAC specific 
antibodies. The antibody concentration is specified in Table 2. The blots were 
probed for beta tubulin to check for equal protein loading. Densitometry 
analysis was performed using Image J 1.34 s software. Western data values 
were normalized with loading control and statistical comparisons were made 
by one way ANOVA with Bonferroni’s post-test analysis using GraphPad 
Prism software (Version 5.0; GraphPad Software, Inc., San Diego, CA). 
p<0.05 was considered statistically significant. 
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2.6 Dissociation of glial cells from murine optic nerve 
14 wks old C57BL/6J female mice were obtained from Jackson Labs. Optic 
nerves were dissected from optic chiasm to the optic nerve head. Small 
pieces of the dissected nerves were incubated in a solution containing DMEM 
with 0.02 M Hepes buffer and 0.25% trypsin (Sigma) in Tris-buffered saline 
(TBS), pH 7.7 with 0.02% collagenase (Worthington, Lakewood, NJ) for 20 
min on a shaker at 37°C. This step was repeated for another 20 min. Nerve 
pieces were transferred to a solution containing trypsin in EDTA solution 
(SAFC Biosciences, Lenexa, Kansas) with 0.02% collagenase and placed on 
a shaker for 20 min at 37°C. Cells were then triturated 10-15 times using 
siliconized glass pipette in DNAse 0.4 µl/ml (Quiagen), trypsin inhibitor 0.05 
mg/ml from Sigma and DMEM (Lonza). The resulting suspension was passed 
through a syringe with 25 gauge needle attached three times and filtered 
through a 0.45 µ mesh. Solution of 10% fetal calf serum (FCS) with sodium 
azide 0.2% in DMEM (Miller, David et al. 1985) was added to the final 
solution. A sample of the suspension was mixed with trypan blue and cells 
were counted using hemocytometer. Cells were diluted to 1.5 x 105 cells/ml 
and 600 µl was added to a cytospin and cells were spun onto vectabond 
coated slides at 8000 rpm for 2 min and imaged on Olympus FV1000 confocal 
microscope. 
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CHAPTER 3. RESULTS IN MICE 
 
3.1 Co-localization of acetylated and methylated histone 
in murine optic nerve glial cells 
In order to examine if the concept of global state of deacetylation in 
differentiated cells holds true, we co labeled murine optic nerve sections with 
markers for acetylated histone (H3K18) and methylated histone (H3K9) using 
triple label immunohistochemistry. Sections of E16, P5 and P30 stages mouse 
optic nerve were triple labeled with DAPI to label nucleus, acetylated histone 
specific to label histone 3 at lysine 18 loci (marker for transcriptionally active 
state) and methylated histone antibody that labels methylated histone 3 at 
lysine 9 (marker for transcriptionally inactive state) (Fig.14). 
   
The analysis of the localization pattern for all the classical HDACs showed that 
the established belief that differentiated glial cells maintain a global state of 
deacetylation on differentiation does not seem to hold true. We did see glial 
cells showing expression of acetylated lysine with in their nucleus at all  the 
three stages of optic nerve that we examined. There were also some cells that 
showed co-label for both the markers as shown by the arrow (Fig.14).
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3.2 HDACs in developing murine optic nerve 
 
3.2.1 mRNA Expression levels in the murine optic nerve glia 
To determine if the large family of HDACs was expressed in the optic nerve, 
quantitative reverse transcription polymerase chain reaction (RT-qPCR) was 
performed on murine optic nerve samples for all the three stages. Three 
different stages of development were chosen for these studies; embryonic 
day 16 (E16) which denotes a period when astrocyte precursors are found in 
the optic stalk, postnatal day 5 (P5) when immature astrocytes and 
oligodendrocytes are found throughout the optic nerve, and P30 when optic 
nerve astrocytes and oligodendrocytes are mature (Dakubo, Wang et al. 
2003; Petros, Williams et al. 2006; Pernet, Joly et al. 2008). RT-qPCR clearly 
indicated that HDACs 1-11 were all expressed during all stages of glial 
development examined in the murine optic nerve (Fig.16-20). Analysis was 
done in two ways. First, mRNA levels for all the HDACs were analyzed for all 
three stages relative to E16. Based on the level of expression of mRNA at P5 
and P30 relative to E16 the HDACs were grouped into two as shown in (Fig.16 
and 17). HDAC5, 9 and 11 were grouped separate from the rest of the classical 
HDACs as their level of expression was found to be lowest at P5 stage compared 
to the other two whereas all the other HDACs were found to have higher lever of 
expression at E16 in comparison to the other two stages. To directly compare the 
levels of mRNA for all the HDACs at a given stage, the data was also graphed so 
that the level of each HDAC mRNA was standardized to HDAC1 (Fig.18-20). 
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Comparatively, HDACs 5, 8, 9, and 10 were lower in levels than the other 
HDACs at E16, while HDAC 5, 8, 9, 10, and 11 were lower than the other HDACs 
at P5. 
 
3.2.2 Patterns of HDAC localization in the developing optic nerve 
The localization of each HDAC was addressed in this study using triple-label 
immunohistochemistry. The specificity of each antibody to be used was initially 
tested by western blot analysis of proteins isolated from E16, P5, and P30 mouse 
optic nerve. Each blot was also probed with β tubulin to normalize protein loading 
for subsequent densitometry readings (Fig.21). The antibodies used for these 
studies are included in Table 2. Unfortunately; many of the antibodies we tested 
appeared not to be specific for proteins of the predicted molecular weight using 
our protocols (Table 3). 
 
To determine the patterns of expression for each HDAC in the developing optic 
nerve glia, sections of mouse optic nerve and optic nerve head were triple- 
labeled with DAPI to show nucleus, SOX2, which labels peripapillary and optic 
nerve glia (Stanke, Moose et al. 2010), and antibodies specific for each HDAC. 
The analysis of expression patterns in the murine optic nerve showed that there 
were 4 basic patterns into which we could group the HDACs; 1) predominantly 
nuclear with no to little cytoplasmic staining, 2) nuclear and cytoplasmic with both 
cytopasmic and nuclear label being apparent, 3) predominantly cytoplasmic with 
little to no nuclear label and 4) variable that showed differential expression 
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pattern depending upon stages examined (see Table 4). HDACs 1 and 2 were 
predominantly nuclear in localization in all the three stages of the murine optic 
nerve studied (Fig.23 and 24). HDACs 4, 6 and 11 showed both nuclear and 
cytoplasmic localization in all the stages (Fig.26, 28 and 32). HDAC5, 9 and 10 
were predominantly found localized to the cytoplasm in all the three stages 
(Fig.27, 30 and 31). HDACs that showed variable response in expression pattern 
were 1) HDAC3 (Fig.25) predominantly cytoplasmic in E16 optic nerve section 
while cytoplasmic only in postnatal day 5 and 30 optic nerve sections studied 
and 2) HDAC8 (Fig.29) being predominantly cytoplasmic in localization at E16 
and P5 stage and both nuclear and cytoplasmic in p30 optic nerve sections.  
 
3.3 Expression of markers for glial cells in murine optic nerve 
To prepare for the experiments in which HDAC activity will be inhibited to test 
their role in glial development, the number of astrocyte and oligodendrocyte 
precursors was quantitated. In order to get an estimate of O2A and astrocyte 
precursors the glial cells of the adult murine optic nerve were dissociated and 
attached to slides using a cytospin. Prepared slides were labeled for specific 
markers for the glial restricted precursors (GRPs) (NG2 -, PDGFRα - and 
A2B5 +), O2A precursors (NG2 +, PDGFRα + and A2B5 +) and astrocytes 
precursors (A2B5 +) (Liu and Rao 2004) (See Fig.43 as an example). 
 
The quantitation of the labeled cells as shown in Fig.44 revealed that all the 
cell types were present. The glial cell precursors predominantly present were 
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O2A precursors (23%), astrocyte precursors/GRPs were found to be lowest 
in numbers (6%). 29% of the cells did not show label with any of the markers 
used for glial precursors and we assume that they may be either the mature 
glial cells types as they could not be identified in the absence of their specific 
markers. 
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CHAPTER 4. RESULTS IN CHICK 
 
 4.1 HDACs in developing chick optic nerve 
 
4.1.1 Co-localization of acetylated and methylated histone 
in chick optic nerve glial cells 
In order to examine if the concept of global state of deacetylation in 
differentiated cells holds true, we co labeled murine optic nerve sections with 
markers for acetylated histone (H3K18) and methylated histone (H3K9) using 
triple label immunohistochemistry. Sections from E5, E8 and E18 chick optic 
nerve were triple labeled with DAPI to show nucleus, acetylated lysine 
antibody to show acetylated histone 3 at lysine 18 position (marker for 
transcriptionally active state) and methylated histone antibody that labels 
methylated histone 3 at lysine 9 position (marker for transcriptionally inactive 
state) (Fig.15). 
 
The analysis of the localization pattern showed, the common belief that 
differentiated glial cells maintain a global state of deacetylation does not seem 
to hold true. We did see glial cells showing expression of acetylated 
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lysine with in their nucleus at all the three stages of optic nerve that we 
examined. There were also some cells that showed co label for both the 
markers as shown by the arrow (Fig.15).  
 
4.1.2 Patterns of HDAC localization in the developing optic nerve 
To determine if there were species-specific differences in expression patterns 
of HDACs, murine patterns were compared with developing chick optic nerve. 
The localization of each HDAC was addressed in this study using triple-label 
immunohistochemistry. The specificity of each antibody to be used was initially 
tested by western blot analysis of proteins isolated from E5, E8, and E18 chick 
optic nerve (Fig.22). Each blot was also probed with β-tubulin which was used to 
normalize protein loading for subsequent densitometry readings. The antibodies 
used for these studies are included in Table 2. 
 
To determine the patterns of expression for each HDAC in the developing chick 
optic nerve, sections were triple-labeled with DAPI to show the nucleus, SOX2, 
which labels peripapillary and optic nerve glia (Stanke, Moose et al. 2010), and 
antibodies specific for each HDAC. Similarly to the murine optic nerve, the 
localization patterns of HDACs were grouped into 4 basic patterns; 1) 
predominantly nuclear, HDACs with little to no cytoplasmic staining pattern, 2) 
nuclear and cytoplasmic were the HDACs showing both nuclear and cytoplasmic 
label, 3) predominantly cytoplasmic were the HDACs with little to no nuclear 
label and 4) variable that showed differential expression patterns depending 
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upon stages (see Table 5). HDAC1 and 2 were predominantly nuclear in 
localization in all the three stages of the chick optic nerve that we studied 
(Fig.33 and 34). HDAC3, 4, 5, 6, 8 and 11 showed both nuclear and 
cytoplasmic localization pattern (Fig.35, 36, 37, 38, 39, and 42). HDAC9 was 
predominantly cytoplasmic in localization in all the three stages (Fig.40). 
Variable expression pattern was observed for HDAC10 which was 
predominantly cytoplasmic at stage E5 and both nuclear and cytoplasmic in 
localization at E8 and E18 stage of optic nerve development (Fig.41). 
 
4.1.3 Expression of markers for the glial cells in murine optic nerve 
To prepare for the experiments in which HDAC activity will be inhibited to test 
their role in glial development, the number of astrocyte and oligodendrocyte 
precursors was quantitated. In order to get an estimate of O2A and astrocyte 
precursors the glial cells of the adult murine optic nerve were dissociated and 
attached to slides using a cytospin. Prepared slides were immunolabeled for 
specific markers for the glial restricted precursors (GRPs) (NG2 -, PDGFRα - 
and A2B5 +), O2A precursors (NG2 +, PDGFRα + and A2B5 +) and 
astrocytes precursors (A2B5 +) (Liu and Rao 2004) (See Fig.45 as an 
example). 
 
The quantitation of the labeled cells as shown in Fig.46 revealed that all the 
cell types were present. The glial cell precursors predominantly present were 
O2A precursors (18.7%), astrocyte precursors/GRPs were found to be lowest 
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in numbers (5%). 56% of the cells did not show label with any of the markers 
used for glial precursors and we assume that that may be the mature glial 
cells or mesenchymal cells as we could not identify the mature cells yet. 
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CHAPTER 5. DISCUSSION 
 
5.1 Summary 
This study sought to determine the expression of classical HDACs during glial 
differentiation in mouse and chick optic nerve using RT-qPCR, western blotting, 
and immunohistochemistry. Our findings can be summarized as follows: 1) 
acetylation of histone 3 during optic nerve differentiation and co-localization of 
both acetylated and methylated histone within the nuclei of the differentiating glial 
cells indicate that both acetylation and deacetylation are required for astrocyte 
and oligodendrocyte development. 2) mRNA and protein for all of the classical 
HDACs were present at all of the developmental stages examined. 3 ) Majority of 
HDACs had similar patterns of mRNA and protein levels over time, with more 
present at earlier and less present at later stages of development. 4 ) The 
localization of the HDACs were grouped into four patterns; predominantly 
nuclear, predominantly cytoplasmic, both nuclear and cytoplasmic, and last a 
variable stage-dependent pattern. 1) HDACs 1 and 2 were predominantly nuclear 
throughout the optic nerve glial cell development in both murine and chick, 2) 
HDAC4, 6 and 11 in mouse and HDAC3, 4, 5, 6, 8 and 11 in chick were localized 
to nucleus as well as cytoplasm, 3) HDAC5, 9 and 10 in 
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mouse and HDAC9 in chick were localized predominantly to the cytoplasm, 4) 
variable pattern in localization were found for HDAC3 and 8 in murine optic nerve 
glial cells and HDAC10 in chick optic nerve glial cells during the different stages 
of development that were studied. 
 
The HDAC localization patterns for chick and mouse were, not surprisingly, quite 
similar to one another. The HDACs which showed different patterns of 
localization in chick and mouse were 3, 5, 8, and 10. HDACs 3 and 8 showed 
relatively conservative changes; for example in chick HDAC3 was found in both 
nucleus and cytoplasm at E8 and E18 stage, whereas in mouse HDAC3 was 
found in both nucleus and cytoplasm at E16 stage in development. HDACs 5 
and 10, on the other hand, showed non-conservative changes; both 5 and 10 
were predominantly localized to the cytoplasm in mouse, but 5 was nuclear and 
cytoplasmic and 10 variable in the chick. 
 
5.2 Cells in the developing optic nerve do not appear to be globally 
acetylated or deacetylated 
Several studies have concluded that differentiating neurons are globally 
acetylated (Hsieh, Nakashima et al. 2004; Schwechter, Millet et al. 2007), while 
other studies have proposed that de-acetylation is the key to the differentiation of 
oligodendrocytes (Marin-Husstege, Muggironi et al. 2002; Shen, Li et al. 2005; 
Liu, Hu et al. 2007; Liu, Hu et al. 2008; Liu, Hu et al. 2009; Swiss, Nguyen et al. 
2011; Conway, O'Bara et al. 2012). Our data showing co label for both 
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methylated and acetylated histone markers is consistent with the possibility of 
combinatorial role of both acetylation and deacetylation in glial cell differentiation 
with in the optic nerve. Methylated histone marker was used to label our slides in 
order to access the state of transcriptional repression as HDACs have been 
shown to be playing an indirect role in methylation of the histone and it was not 
possible for us to co label all the sections with 11 different HDACs. 
 
5.3 Effect of HDAC inhibition on the differentiation of the 
glial cells in optic nerve 
Studies have shown the role of HDACs in the differentiation of neurons and 
oligodendrocytes (Marin-Husstege, Muggironi et al. 2002; Siebzehnrubl, Buslei et 
al. 2007). Of all the classical HDACs, HDAC1, 2 and 11 have been shown to play 
significant role in the differentiation of oligodendrocytes (Liu, Hu et al. 2009; Ye, 
Chen et al. 2009). Inhibition of HDACs brings changes in the number of 
astrocytes (Marin-Husstege, Muggironi et al. 2002; Hsieh, Nakashima et al. 
2004; Siebzehnrubl, Buslei et al. 2007). HDAC activity appears to play a role in 
cells arising from the ganglionic eminences of the telencephalon in which the 
HDACs act as a fate switch from neurons to astrocytes (Shaked, Weissmuller et 
al. 2008). However, the epigenetic role of the HDACs in the differentiation of 
astrocytes in the optic nerve is yet not fully understood. Some of our data is 
consistent with the idea that optic nerve astrocytes and oligodendrocytes might 
require deacetylation for their differentiation; we found there are seven of the 
classic HDACs (1, 2, 3, 6, 8, 10, 11) present in the nucleus in at least one or 
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more stages during the differentiation. However, our data are consistent with 
many more HDACs being involved in the process than HDAC1, 2 and 11 
proposed by other investigators. In order for us to determine exactly which 
HDACs are involved in gliogenesis, much more needs to be understood 
concerning the gene targets and interacting partners for each HDAC. 
 
5.4 Targets of different HDACs 
HDACs do not come directly in contact with DNA; rather, a complex group of 
proteins recruit HDACs to specific cis-acting elements on the untranslated 
regulatory regions in the genome (Torchia, Glass et al. 1998). Transcription 
factors, co-repressors, and/or co-activators, are some important members of this 
complex protein machinery (Ballas and Mandel 2005). The repressor element 
transcription factor (REST-Co-REST) complex, a well-known suppressor for 
neuronal genes, is an example of such transcriptional regulation. REST, an 
important transcription regulator that interacts with repressor element 1 (RE1) 
sites on neuronal genes, serves as a binding site for Co-repressor (Co-REST) 
(Andres, Burger et al. 1999). Histone modifying enzymes, especially HDAC1 and 
2 then bind to the repression domains present on Co-REST and are recruited to 
the specific loci on histone tails, thereby leading to the deacetylation of the lysine 
chains (Abrajano, Qureshi et al. 2009). We specifically focused on determining 
HDACs that were found in the nucleus at one or more stages of development to 
narrow down which HDACs may modify histones, and by extension play a role in 
gene regulation. HDACs, once known to target only the histone proteins, are 
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now known to interact with many non-histone proteins as well. They have been 
shown to interact with other proteins when present in the cytoplasm as well. 
Various proteins have shown a change in their structural and functional ability as 
a result of deacetylation by the HDACs. For instance, HDAC6 has been 
established to interact with cytoplasmic proteins like tubulin and chaperons like 
heat shock protiens (Hsp90), causing changes in the contractile functions of the 
muscles (Marks and Xu 2009). Similiarly, HDAC8 has been shown to deacetylate 
heat shock protein 20 (Hsp20) in the myometrium (Karolczak-Bayatti, Sweeney 
et al. 2011). HDACs also bring about changes to the proliferation and 
differentiation of cells by targeting transcriptional factors (p53, HIF1α, E2F, p21, 
c-Myc and Bcl-6), signaling mediators (STAT3, SMAD7), DNA repair enzymes 
(Ku70) and nuclear import proteins like importin-α7 (Dokmanovic, Clarke et al. 
2007; Marks and Xu 2009). 
 
The role of HDACs during the differentiation of neurons, astrocytes and 
oligodendrocytes has been tested using HDAC inhibitors such as trichostatin A 
(TSA). Studies have shown alteration in the expression of neuronal genes like 
Neurod D1, Hes1, Numb, astrocytic genes like BMP6, S100β and genes related 
to oligodendrocytes differentiation like PDGFRα, Sox6 and Hes5 (Swiss, Nguyen 
et al. 2011). Last but not least, HDACs have also found to effect renal 
development by regulation of transcription factors like PAX2, PAX8 and p21 
(Rosenberg, Chen et al. 2011). 
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Studies suggesting the role of HDAC inhibitors (TSA, sodium butyrate, SAHA 
and Valproic acid) as treatment options for various cancers and diseases like 
Parkinsonism, Alzheimer and many others suggests that there is a wide area 
that still needs to be explored regarding the role of HDACs with various 
regulatory proteins and understanding the mechanism involved (Zarate, Singh et 
al. 2006). 
 
5.5 HDACs as transcriptional activators 
HDACs have been well established to play a role in transcriptional repression via 
deacetylation of histones, but studies related to gene regulation have now shown 
that this does not always hold true (Pazin and Kadonaga 1997; Nusinzon and 
Horvath 2005). HDACs have been shown to act as transcriptional activators 
under certain situations. Examples include: 1) HDAC1 regulation of the 
transcriptional machinery for the MMTV promoter (Smith 2008), 2) HDAC1 and 2 
act as transcriptional activators for the B cell lymphoma 2 (bcl2) gene, a well-
known anti-apoptotic gene (Duan, Heckman et al. 2005), and 3) HDAC6 
upregulation of interferon β (IFNβ) (Nusinzon and Horvath 2006; Smith 2008). 
Hence, it is quite possible that some of the nuclear localized HDACs in our study 
may be acting as transcriptional activators. 
 
5.6 Conclusions 
All the classical HDACs are present in the glial cells, during different stages of 
development in both murine and chick optic nerve. Based on the localization 
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pattern we could categorize the classical HDACs into four different groups; 
predominantly nuclear, nuclear and cytoplasmic, predominantly cytoplasmic and 
variable. Six of the classical HDACs (1, 2, 3, 4, 6, and 11) are present in the 
nucleus in at least one or more stages during glial cell differentiation in murine 
optic nerve whereas nine of the classical HDACs (1, 2, 3, 4, 5, 6, 8, 10 and 11) 
have been found to be localized to the nucleus at one or more stages of glial 
cells development in chick optic nerve. Understanding the localization pattern of 
HDACs in optic nerve will help us to study their epigenetic role in the 
differentiation of the glial cell types in the optic nerve, an area that has not been 
yet fully explored. 
 
In conclusion this project has provided an insight into which HDACs are nuclear 
in localization within optic nerve glia. It sets a platform for further research to 
determine the epigenetic role of these HDACs in the development of glial cell 
types. Further, our data also provide a baseline for understanding potential role 
of epigenetic changes that occur during disease processes such as glaucoma 
and diabetes. 
5.7 Future directions 
To further understand the role of HDACs during the glial cell differentiation in 
optic nerve we are focused on answering the following questions: 
1) Which of the classical HDACs are playing a direct role in the differentiation of  
glial cells in the optic nerve? 
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2) What changes in the differentiation of oligodendrocytes and astrocytes in the 
optic nerve will take place when we inhibit HDAC activity? 
3) Which genes do the various HDACs target during glial differentiation? 
4) What happens to HDAC activity during diseases such as glaucoma and 
diabetes that affect the optic nerve?
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             Table 1 List of primers used in qPCR 
 
Gene 
 
Accession 
Number 
 
Primer 
 
Sequence 
Product 
Length 
(bp)  
 
HDAC1 
NM_008228.2 Forward 
TGGGGCTGGCAAAGGCAAGT  
 
130  
Reverse 
GACCACTGCACTAGGCTGGAACA 
 
 
HDAC2 
NM_ 008229.2 Forward CGTACAGTCAAGGAGGCGGCAA  
 
    97  
Reverse 
TGAGGCTTCATGGGATGACCCTGG 
 
 
HDAC3 
NM_010411.2 Forward 
ACGTGCATCGTGCTCCAGTGT  
 
150  
Reverse 
AGTGTAGCCACCACCTCCCAGT 
 
 
HDAC4 
NM_207225.1 Forward 
AGCTCTGGCAACGTCAGCACT  
 
114  
Reverse 
AAGTGGGGCGACTGAGCCTTCT 
 
 
HDAC5 
 NM_ 001077696.1 
 
Forward AAAACGTAAATGTGGCGTGGACAGGA  
 
    147  
Reverse 
TTCAACAGCATCAAACCCAGGCGGA 
 
 
HDAC6 
NM_ 010413.3 Forward 
TGGGGCTTCAAGG GCTGGATCT 
 
 
 
 
    148  
Reverse 
TGCTCTCTGATGGC ATGGAGCC 
 
 
 
HDAC7 
NM_001204275.1 Forward 
GCTCAGCATGTGCATGTGGAACAC 
 
 
 
132  Reverse 
TGAGAGCCTGGTGTGTCTGGCT 
 
 
 
HDAC8 
NM_ 027382.3 Forward 
ATGACACCAGTGGTCGGCAA  
 
105  
Reverse 
ACGAGCCGTGTTGGCAAGGTT 
 
 
HDAC9 
NM_ 024124.3 Forward 
TGCACCTTTGCCTCAGAGCACG  
 
 150  
Reverse 
TGGCTGCCTGGTTGCTTCAGT 
 
 
HDAC10 
NM_ 199198.2 Forward 
TAGCAGCCAAACATGCCAAGCAGA  
 
          143  
Reverse 
ATGCTCATAGCGGTGCCAAGAGAAA 
 
 
HDAC11 
NM_ 144919.2 Forward 
GCTGGGAAATGGGGCAAGGTGA  
 
         134  
Reverse 
AGCTCGTTGAGATAGCGCCTCGT 
 
 
β2 micro 
globulin 
NM_ 009735.3 Forward 
TCGCGGTCGCTTCAGTCGTC  
 
 116  
Reverse 
CATTCTCCGGTGGGTGGCGTG 
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Table 2 List of antibodies used for western blots and immunofluorescence 
Antibody Source Antibody Dilution Peptide Supplier 
IHC Westerns 
Rabbit  Anti-HDAC 
1 
(Cat # ab33278) 
Abcam 
(Cambridge, MA) 
1:300 1:2500 Abcam 
(Cambridge, MA) 
Mouse Anti-HDAC 
2 
(Cat # ab12169) 
Abcam 
(Cambridge, MA) 
1:350 1:2500 Abcam 
(Cambridge, MA) 
Rabbit  Anti-HDAC 
3 
(Cat # ab16047) 
Abcam 
(Cambridge, MA) 
1:300 1:2500 Abcam 
(Cambridge, MA) 
Mouse  Anti-HDAC 
4 
(21CB-HDAC4) 
21st Century 
(Marlboro, MA) 
1:100     1:1000 21st Century 
(Marlboro, MA) 
Rabbit  Anti-HDAC 
5 
(Cat # ab53693) 
Abcam 
(Cambridge, MA) 
1:100 1:500 Santa Cruz 
(Santa Cruz, CA) 
Rabbit  Anti-HDAC 
6 
(Cat #LSB5253) 
Life Span 
Biosciences 
(Seattle, WA) 
1:250 1:500 Santa Cruz 
(Santa Cruz, CA) 
Rabbit  Anti-HDAC 
8 (Cat # sc11405) 
Lif  Span 
Biosciences 
(Seattle, WA) 
1:500 1:1000 Life Span 
Biosciences 
Rabbit  Anti-HDAC 
9 
(Cat #  ab59718) 
Abc m 
(Cambridge, MA) 
1:250 1:500 Abcam 
(Cambridge, MA) 
Rabbit  Anti-HDAC 
10 
(Cat # NB100-
91801) 
Novus Biologicals 
(Littleton, Co) 
1:100 1:500   Santa Cruz 
   (Santa Cruz, 
CA) Rabbit  Anti-HDAC 
1  
(Cat #GTX116403 
) 
GeneTex 
(Irvine, CA) 
1:100 1:500 Santa Cruz 
(Santa Cruz, CA) 
Rabbit Anti-
Acetylated 
histone (Cat# 
ab1191) 
Abcam 
(Cambridge, MA) 
1:100 N/A N/A 
Goat Anti-SOX2 
(Cat # sc17320) 
Santa Cruz 
(Santa Cruz, CA) 
1:250 N/A N/A 
Mouse anti-  
tubulin 
(Cat # T0198) 
Sigma 
(St. Louis, MO) 
N/A 1:1000 N/A 
Mouse Anti-
methylated histone 
(cat# ab1220) 
Abcam 
(Cambridge, MA) 
1:300 N/A N/A 
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Table 3 List of unsuccessful antibodies 
Primary 
Antibody 
Catalogue No. Source 
HDAC 4 AP08440PU-N Acris 
HDAC 4 ab79521 Abcam 
HDAC 4 HO163 Sigma 
HDAC 4 PA1-25454 Thermo 
Scientific 
HDAC 5 ab1439 Abcam 
HDAC 5 2082 Cell 
Signalling 
HDAC 5 AP02669PU-N Acris 
HDAC 5 PA1-14188 Thermo 
Scientific 
HDAC7 3607-100 Bio Vision 
HDAC7 CB-HDAC7 21st century 
HDAC7 LS-C118482  Life Span 
Biosciences  
HDAC7 IHC-00283 Bethyl 
Laboratories 
HDAC7 LS-B7206 Life Span 
Biosciences 
HDAC 11 ab18973 ABCAM 
HDAC 11 07-1548 Millipore 
HDAC 11 (Y-25) sc-130776 Santa Cruz 
HDAC 11 (N- 
term) 
AP1111a Abgent 
Rabbit Anti- 
HDAC 11 
Cat # PA5- 
11250 
Thermo 
Scientific 
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Table 4 Localization of HDACs in murine optic nerve 
    
Stages 
Predominantly 
 
  nuclear 
Nuclear and 
 
cytoplasmic 
Predominantly 
 
cytoplasmic 
     Variable 
 
E16 
 
1 and 2 
 
4, 6 and 11 
 
5, 9 and 10 
  HDAC3 and 8         
(Predominantly  
  cytoplasmic) 
 
 
P5 
 
1 and 2 
 
4, 6 and 11 
 
5, 9 and 10 
    HDAC3   
(cytoplasmic)  
   HDAC8 
(Predominantly 
cytoplasmic) 
 
 
       P30 
 
1 and 2 
 
4, 6 and 11 
 
5, 9 and 10 
    HDAC3    
(cytoplasmic)  
   HDAC8 
  (Nuclear and   
  cytoplasmic) 
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Table 5 Localization of HDACs in chick optic nerve 
Stages Predominantly 
 
nuclear 
Nuclear and 
 
cytoplasmic 
Predominantly 
 
cytoplasmic 
     Variable 
 
E5 
 
1 and 2 
 
3,4, 5, 6,8 and 
11 
 
 9  
   
    HDAC10         
(Predominantly  
  cytoplasmic) 
 
 
E8 
 
1 and 2 
 
3,4, 5, 6,8 and 
11 
 
9 
    
  HDAC10    
  (Nuclear and   
  cytoplasmic) 
 
 
 
E18        
 
 1 and 2 
 
3,4, 5, 6,8 and 
11 
 
9 
    
  HDAC10     
  (Nuclear and   
  cytoplasmic) 
 
 
67 
 
 
FIGURES
 
 
67 
 
 
 
 
Fig.1 Glial cells in the central nervous system: Cells in the central nervous 
system are broadly grouped as neurons and the glial cells. Glial cells are further 
divided mainly into two groups; macroglia or microglia cells (Bergmann, Lane et 
al. 2006). 
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Fig.2 Specification of astrocytes: Both ciliary neurotrophic factor leukemia 
inhibitory factor and bone morphogenetic protein pathway function in parallel 
thereby inducing GFAP expression. This is thought to be a common 
mechanism by which most of the astrocytic genes might be regulated 
(Kessaris, Pringle et al. 2008).  
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Fig.3 SHH signaling pathway: A-B show the SHH signaling pathway in 
vertebrates. (A) Precursor SHH is converted to N-SHH. It is N-SHH that is 
responsible for the signaling in vertebrates. (B) When SHH binds to PTC, the 
inhibition on SMO is released, this in turn activates GLI family of transcription 
factors by inhibiting phosphorylating activity of PKA. PKA along with fused 
(Fu) and [Su (Fu)] regulate the nuclear localization of GLI (Marti and 
Bovolenta 2002).  
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Fig.4 Differentiation of the astrocytic lineage cells in the optic nerve: Mature 
astrocytes are formed through progressive stages of differentiation. Three 
different stages of paired homeobox 2 (PAX2) positive astrocytic lineages 
have been described in the optic nerve; 1) Astrocyte precursor cells (APCs) 
are PAX2 +, vimentin +, and GFAP -, 2) Immature perinatal astrocytes are 
PAX2 +, vimentin +, and GFAP + and 3) Mature perinatal astrocytes are PAX2 
+, vimentin -, and GFAP ++ (Chu, Hughes et al. 2001).  
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Fig.5 Stages of differentiation for oligodendrocytes: Oligodendrocytes, like 
astrocytes, also undergo process of differentiation through various stages of 
maturation. Specific markers have been established to identify the different 
stages of differentiation for oligodendrocytes, precursors, immature as well as 
mature (Jackman, Ishii et al. 2000).  
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Fig.6 Chromatin structure and level of organization: Nucleosomes are 
composed of a core of the histone octamer, H2A, H2B, H3, and H4, with DNA 
being wrapped around the histones. DNA and protein inside the nucleus of the 
cell constitute the chromatin network (Essential cell biology 2nd ed, 2004). 
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Fig.7 Histone acetylation and transcriptional activation: Histone acetylation 
and deacetylation is controlled by the histone acetyltransferase (HATs) and 
the histone deacetylase (HDACs) families of enzymes. Acetylation neutralizes 
the positive charge on the histones chains and decreases the ability of the 
histones to bind to DNA. This decreased binding allows to open up the DNA 
that provides access to the transcription factors to the sites they must bind to 
in order to affect transcription (Korzus 2010).  
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Fig.8 Classification of histone deacetylase enzymes: HDACs have been 
classified into four major groups based on their sequence similarities. The 
classical HDACs are categorized into class 1 (HDAC1, 2, 3 and 8), class II 
(HDAC4, 5, 6, 7, 9, and 10), and class IV (HDAC11) on the basis of their 
homology to yeast proteins. Class 3 in mammals includes the sirtunins and is 
also known as the atypical HDACs. In the figure DNA catalytic domains are 
shown in pink, the nuclear localization signal in purple,(Karagiannis and Maulik 
2012).
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Fig.9 Transcription initiation complex: Transcriptional unit in eukaryotes is 
made up of enhancer, core promoter, also known as the transcription start 
site and initiator element. Transcription factors are involved in the initiation of 
gene transcription along with RNA polymerase II (Levine and Tjian 2003).
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Fig.10 Expression of markers for the glial cells: Glial restricted precursors 
(GRPs) differentiate into either oligodendrocytes or astrocytes and are known 
to be positively stained for A2B5. Polydendrocytes can differentiate either into 
oligodendrocytes or other cell types and are stained positively with both NG2 
and PDGFRα. O2A precursors are A2B5 +, NG2 + and PDGFRα + and can 
either give rise to both oligodendrocytes and type 2 astrocytes (Liu and Rao 
2004).  
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Fig.11 Vertebrate eye development: Developement of the eye takes place 
with the bifurcation of the eye field into two as the neural plate begins to form 
neural tube (a-d). As this is occurring, the two pits on either side now become 
optic grooves which further enlarge to form the optic vesicles (e). Optic 
vesicle further invaginate to form the double layered optic cup (g). The inner 
part of the optic cup becomes the multi-layered neural retina and the outer layer 
becomes the retinal pigment epithelium (Lamb, Collin et al. 2007).  
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Fig.12 Margins of optic cup enlarging and sealing off at the choroidal fissure: 
The choroid fissure has been described to develop in the ventral optic cup 
due to the invagination of optic vesicle.It is the opening from where optic 
nerve is believed to exit the eye Hyaloid vessels run through this choroidal 
fissure. As development progresses the choroid fissure closes eventually as 
a result of continued proliferation of the two lips of the ventral retina adjacent 
to the fissure and eventual fusion of the two lips together to form the 
complete globe (Onwochei, Simon et al. 2000). 
.
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Fig.13 Mature retina and the retinal cell types: The retina has been shown to 
be made up of different layers; 1) the retinal pigment epithelium (RPE), 2) the 
outer nuclear layer contains the rod and cone photoreceptors, 3) the outer 
plexiform layer contains synaptic contact between the photoreceptors, bipolar 
cells and horizontal cells, 4) the inner nuclear layer contains amacrine cells, 
horizontal cells, bipolar cells and muller glial cells, 5) inner plexiform layer 
consists of synapses between the bipolar, amacrine and the ganglion cells, 6) 
ganglion cell layer contains the ganglion cells, misplaced amacrine cells and 
retinal astrocytes and 7) nerve fibre layer carrying axons from ganglion cells 
(Kolb 1995).  
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Fig.14 Histone acetylation and methylation in glial cells in murine optic nerve: 
Low magnification view of the P30 optic nerve, optic nerve head and retina 
(B) and plane of imaging to aid in orientation of the sections is shown in C. 
Drawing A shows the plane of sectioning for the optic nerve. Confocal 
imaging of AcH3K18, MethH3K9, and DAPI triple label of sections of murine 
optic nerve at E16 (D, E, F and G), P5 (H, I, J and K) and P30 (L, M, N and 
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O). Overlay of acetylated histone (green) and methylated histone marker (red) 
for all three stages (G, K and O) depicts glial cells during differentiation show 
localization of acetylated histone as well as methylated histone within their 
nuclei. Higher magnification views as shown in 60x magnification panels 
(insets G, K and O) show co-localization for both the markers. Arrows in 
panels D-G, H-K and L-O are pointing to the cells that show label for both the 
markers whereas the arrow heads are pointing to the cells that do not show a 
co label. Scale bars: (B) Bar = 50 µm, (G) Bar = 50 µm for images D-O.  
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Fig.15 Histone acetylation and methylation in glial cells in chick optic nerve: 
Low magnification view of the E8 and E18 optic nerve, optic nerve head and 
retina (B) and plane of imaging to aid in orientation of the sections is shown in 
C. Drawing A shows the plane of sectioning of the optic nerve. Confocal imaging of 
AcH3K18, MethH3K9, and DAPI triple label of sections of murine optic nerve at E5 
(D, E, F and G), E8 (H, I, J and K) and E18 (L, M, N and O). Overlay of 
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acetylated histone (green) and methylated histone marker (red) (G, K and O) 
shows that the glial cells during differentiation show localization of acetylated 
histone as well as methylated histone within their nuclei. Higher magnification 
views as shown in 60x magnification panels (insets G, K and O) show co 
localization for both the markers. Arrows in panels D-G, H-K and L-O are 
pointing to the cells that show label for both the markers whereas the arrow 
heads are pointing to the cells that do not show a co label. Scale bars: (B) 
Bar = 50 µm for images B-C, (G) Bar = 50 µm for images D-O. Scale bars: (G) 
Bar = 50 µm for images D-O.  
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Fig.16 HDACs expression levels in murine optic nerve part A: qPCR analysis 
of the relative levels of HDACs expression in P5 and P30 murine optic nerve 
compared to the levels of the E16 murine optic nerve.  
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Fig.17 HDACs expression levels in murine optic nerve part B: qPCR analysis 
of the relative levels of HDACs expression in P5 and P30 murine optic nerve 
compared to the levels of the E16 murine optic nerve.  
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Fig.18 HDACs expression levels in E16 murine optic nerve: qPCR analysis of 
the relative levels of HDACs expression in E16 murine optic nerve compared to 
the levels of the HDAC1.  
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Fig.19 HDACs expression levels in P5 murine optic nerve: qPCR analysis of 
the relative levels of HDACs expression in P5 murine optic nerve compared to 
the levels of the HDAC1.  
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Fig.20 HDACs expression levels in P30 murine optic nerve: qPCR analysis of 
the relative levels of HDACs expression in P30 murine optic nerve compared to 
the levels of the HDAC1.  
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Fig.21 Expression of HDACs in murine optic nerve: Western blot analysis of 
HDAC proteins in E16, P5 and P30 murine optic nerve. B lots were been 
normalized to β  tubulin. Densitometry shown is relative to E16 stage. 
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Fig.22 Expression of HDACs in chick optic nerve: Western blot analysis of 
HDAC proteins in E5, E8 and E18 chick optic nerve. Densitometric analysis 
of blots has been normalized to tubulin and graphs show values relative to 
E5 stage.  
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Fig.23 Localization of HDAC1 in murine optic nerve: Drawing in A depicts the 
plane of the sections through the optic nerve and optic nerve head. Low 
magnification of the optic nerve, optic nerve head and retina double-labeled for 
SOX2 (glia) and HDAC1 is shown in B to indicate the region which was 
imaged. A drawing depicting the region that was imaged each of the following 
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figures is shown in C. Confocal imaging of HDAC1, SOX2, and DAPI triple-
label in murine optic nerve at E16 (D, E, F and G), P5 (H, I, J and K) and P30 
(L, M, N and O). Each stage shows the overlay of SOX2 and DAPI to aid in 
orientation of the image (D, H, and L). Subsequent overlays did not include DAPI 
because it appeared to obscure some of the SOX2 and HDAC label. HDAC1 label 
is shown (E, I, M), while co-label of SOX2 and HDAC1 is shown at 40x (F, J, N) and 
60x (G, K, O). Images taken at 60x also include higher magnification views (insets 
G, K, O). Arrows indicate nuclei that were co-labeled with SOX2 and HDAC1, 
arrow heads in higher magnification point to the cells that do not show co label. 
Sections from each stage were also incubated with antibody preabsorbed with 
peptide against which the antibody was raised to show antibody specificity (P, Q 
and R). Scale bars: (A) Bar = 50 µm (D) Bar = 50 µm for panels E-G, H-J and L-
N (E) Bar = 50 µm for images G, K and O.  
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Fig.24 Localization of HDAC2 in murine optic nerve: Low magnification view of 
the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A.Confocal imaging of SOX2, HDAC2, and DAPI triple 
label of sections of murine optic nerve at E16 (B, C, D and E), P5 (F, G, H and 
I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown 
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to aid in localization of the optic nerve and optic nerve head (B, F, J). DAPI is 
not included in subsequent overlays because it appeared to obscure some of 
the other immunolabel. HDAC2 only label is shown (C, G, K) as well as SOX2 
and HDAC2 overlay at 40x (D, H, L) and 60x magnifications (E, I, M). Higher 
magnification views are shown in 60x magnification panels (insets E, I, M). 
Double-label indicates that HDAC2 is predominantly localized to the nuclei of 
optic nerve glia. Arrows indicate nuclei that are co–labeled whereas the 
arrowheads in higher magnication(E, I and M) point to the cells that do not 
show co label. Peptide controls (N, O and P) for all the three stages were run 
after pre absorption with the primary antibody to verify the specificity of the 
HDAC2 antibody. Scale bars: (A) Bar = 50 µm (B) Bar = 50 µm for panels B-D, 
F-H and J-L (E) Bar = 50 µm for images E, I and M. 
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Fig.25 Localization of HDAC3 in murine optic nerve: Low magnification view 
of the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A. Confocal imaging of SOX2, HDAC3, and DAPI triple 
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label of sections of murine optic nerve at E16 (B, C, D and E), P5 (F, G, H and 
I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown 
to aid in localization of the optic nerve and optic nerve head (B, F, J).DAPI is 
not included in subsequent overlays because it appeared to obscure some of 
the other immunolabel. HDAC3 only label is shown (C, G, K) as well as SOX2 
and HDAC3 overlay at 40x (D, H, L) and 60x magnifications (E, I, M). Higher 
magnification views are shown in 60x magnification panels (insets E, I, M). 
Double-label indicates that HDAC3 shows variable pattern, localized to the 
nucleus and cytoplasm of optic nerve glia at E16 as few cells show co-
localization of HDAC3 and SOX2. In P5 and P30 optic nerve glia HDAC3 was 
localized predominantly to the cytoplasm. Arrows indicate nuclei that are co–
labeled and arrow heads point to the cells that do not show co label. Peptide 
controls (N, O and P) for all three stages after preabsorption to verify the 
specificity of the antibody. Scale bars: (A) Bar = 50 µm (B) Bar = 50 µm (B-D, F-
H) and J-L (E) Bar = 50 µm for E, I and M.  
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Fig.26 Localization of HDAC4 in murine optic nerve: Low magnification view 
of the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A. Confocal imaging of SOX2, HDAC4, and DAPI triple 
label of sections of murine optic nerve at E16 (B, C, D and E), P5 (F, G,H and 
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I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization of the optic nerve and optic nerve head (B, F, J). 
DAPI is not included in subsequent overlays because it appeared to obscure 
some of the other immunolabel. HDAC4 only label is shown (C, G, K) as well 
as SOX2 and HDAC4 overlay at 40x (D, H, L) and 60x magnifications (E, I, 
M). Higher magnification views are shown in 60x magnification panels (insets 
E, I, M). Double-label indicates that HDAC4 is localized to the nucleus as well 
as to the cytoplasm of optic nerve glia. Arrows indicate nuclei that are co–
labeled and the arrowheads are pointing to the cells that do not show co 
label. Peptide controls (N, O and P) for all the three stages were run after pre 
absorption with the primary antibody to verify the specificity of the HDAC4 
antibody. Scale bars: (A) Bar = 50 µm (B) Bar = 50 µm for panels B-D, F-H and 
J-L (E) Bar = 50 µm for images E, I and M. 
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Fig.27 Localization of HDAC5 in murine optic nerve: Low magnification view 
of the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A Confocal imaging of SOX2, HDAC5, and DAPI 
triple label of sections of murine optic nerve at E16 (B, C, D and E), P5 (F, G, 
100 
 
 
H and I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization of the optic nerve and optic nerve head (B, F, J). 
DAPI is not included in subsequent overlays because it appeared to obscure 
some of the other immunolabel. HDAC5 only label is shown (C, G, K) as 
well as SOX2 and HDAC5 overlay at 40x (D, H, L) and 60x magnifications (E, 
I, M). Higher magnification views in 60x magnification panels (insets E, I, M). 
Double-label shows that HDAC5 is localized predominantly to the cytoplasm 
of optic nerve glia. Arrows indicate nuclei that are co–labeled whereas the 
arrowheads point to the cells that do not show co label. Peptide controls (N, O 
and P) for all the three stages were run after pre absorption with the primary 
antibody to verify the specificity of the antibody. Scale bars: (A) Bar = 50 µm 
(B) Bar = 50 µm for B-D, F-H and J-L (E) Bar = 50 µm for E, I and M.  
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Fig.28 Localization of HDAC6 in murine optic nerve: Low magnification view of 
the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A.Confocal imaging of SOX2, HDAC6, and DAPI triple 
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label of sections of murine optic nerve at E16 (B, C, D and E), P5 (F, G, H and 
I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown 
to aid in localization of the optic nerve and optic nerve head (B, F, J). DAPI is 
not included in subsequent overlays because it appeared to ob scure some of 
the other immunolabel. HDAC6 only label is shown (C, G, K) as well as SOX2 
and HDAC2 overlay at 40x (D, H, L) and 60x magnifications (E, I, M). Higher 
magnification views are shown in 60x magnification panels (insets E, I, M). 
Double-label indicates that HDAC6 is localized to the nucleus and cytoplasm 
of optic nerve glia. Arrows indicate nuclei that are co–labeled and arrow 
heads are pointing to the cells that do not show co label. Peptide controls (N, 
O and P) for all the three stages were run after pre absorption with the primary 
antibody to verify the specificity of the HDAC6 antibody. Scale bars: (A) Bar = 
50 µm (B) Bar = 50 µm for panels B-D, F-H and J-L (E) Bar = 50 µm for images 
E, I and M.  
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Fig.29 Localization of HDAC8 in murine optic nerve: Low magnification view 
of the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A. Confocal imaging of SOX2, HDAC8, and DAPI triple 
label of sections of murine optic nerve at E16 (B, C, D and E), P5 (F, G, H and 
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I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown 
to aid in localization of the optic nerve and optic nerve head (B, F, J).DAPI is 
not included in subsequent overlays because it appeared to obscure some of 
the other immunolabel. HDAC8 only label is shown (C, G, K) a s well as 
SOX2 and HDAC2 overlay at 40x (D, H, L) and 60x magnifications (E, I, M). 
Higher magnification views are shown in 60x magnification panels (insets E, 
I, M). Double-label indicates that HDAC8 has a variable pattern of 
localization. It is localized predominantly to the cytoplasm of optic nerve glia 
at E16 and p5 stage and is localized to the nucleus as well as to the 
cytoplasm at P30 stage. Arrows indicate the cells that show the localization 
pattern clearly while the arrow heads point to the ones that donot show co 
label. Peptide controls (N, O and P) for all the three stages were run after pre 
absorption with the primary antibody to verify the specificity of the antibody. 
Scale bars: (A) Bar = 50 µm (B) Bar = 50 µm for panels B-D, F-H and J-L (E) 
Bar = 50 µm for images E, I and M.  
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Fig.30 Localization of HDAC9 in murine optic nerve: Low magnification view of 
the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A. Confocal imaging of SOX2, HDAC9, and DAPI triple 
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label of sections of murine optic nerve at E16 (B, C, D and E) , P5 (F, G, H and 
I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown 
to aid in localization of the optic nerve and optic nerve head (B, F, J). HDAC9 
only label is shown (C, G, K) SOX2 and HDAC9 overlay at 40x (D, H, L) and 60x 
magnifications (E, I,M). Higher magnification views in 60x magnification panels 
(insets E, I, M). Double-label indicates that HDAC9 is localized predominantly to 
the cytoplasm of optic nerve glia. Arrows indicate nuclei that are co–labeled 
whereas the arrowheads are pointing to the cells that do not show co label. 
Peptide controls (N, O and P) after pre absorption with the primary antibody to 
verify the specificity of the antibody. Scale bars: (A) Bar = 50 µm (B) Bar = 50 
µm for panels B-D, F-H and J-L (E) Bar = 50 µm for images E, I and M.
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Fig.31 Localizationof HDAC10 in murine optic nerve: Confocal imaging of 
SOX2, HDAC10, and DAPI triple label of sections of murine optic nerve at 
E16 (B, C, D and E), P5 (F, G, H and I) and P30 (J, K, L and M). SOX2 and 
DAPI (blue) is shown to aid in localization of the optic nerve and optic nerve 
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head (B, F, J). HDAC10 only label is shown (C, G, K) Images showing SOX2 
and HDAC10 colabel in lower magniication, 40x (D, H, L) and 60x 
magnifications (E, I, M). Higher magnification views in 60x magnification 
panels (insets E, I, M). Double-label indicates that HDAC10 is localized 
predominantly to the cytoplasm of optic nerve glia. Arrows indicate that are 
co–labeled nuclei whereas the arrowheads are pointing to the cells that do 
not show co label. Peptide controls are shown in N, O and P to verify their 
specificity Scale bars: (A) Bar = 50 µm (B) Bar = 50 µm B-D, F-H and J-L (E) 
Bar = 50 µm E, I and M.  
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Fig.32 Localization of HDAC11 in murine optic nerve: Low magnification view 
of the P30 optic nerve, optic nerve head and retina to aid in orientation of the 
sections is shown in A.Confocal imaging of SOX2, HDAC11, and DAPI triple 
label of sections of murine optic nerve at E16 (B, C, D and E), P5 (F, G, H and 
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I) and P30 (J, K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown 
to aid in localization of the optic nerve and optic nerve head (B, F, J). DAPI is 
not included in subsequent overlays because it appeared to obscure some of 
the other immunolabel. HDAC11 only label is shown (C, G, K) as well as 
SOX2 and HDAC2 overlay at 40x (D, H, L) and 60x magnifications (E, I, M). 
Higher magnification views are shown in 60x magnification panels (insets E, 
I, M). Double-label indicates that HDAC11 is localized to the nucleus and 
cytoplasm of optic nerve glia. Arrows indicate nuclei that are Co-labeled and 
arrow heads are pointing to the cells that do not show co label. Peptide 
controls (N, O and P) for all the three stages were run after pre absorption with 
the primary antibody to verify the specificity of the HDAC11 antibody. Scale 
bars: (A) Bar = 50µm (B) Bar = 50 µm for panels B-D, F-H and J-L (E) Bar = 50 
µm for images E, I and M.  
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Fig.33 Localization of HDAC1 in chick optic nerve: Drawing A depicts the 
plane of the sections through the optic nerve and optic nerve head. D 
represents the  plane of imaging showing the region that was imaged. Low 
magnification view of the E8 (B) and E18 (C) optic nerve, optic nerve head and 
retina is shown to aid in orientation of the sections. Pecten in image C 
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represents the vascularised part of the chick retina. Confocal imaging of SOX2, 
HDAC1 and DAPI triple label of sections of chick optic nerve at E5 (E, F and 
G), E8 (I, J and K) and E18 (M, N and O). Overlay of SOX2 (green) and DAPI 
(blue) is shown to aid in localization of the optic nerve and optic nerve head (E, 
I and M). DAPI is not included in all overlays as it appeared to obscure 
immunolabel. HDAC1 only label is shown (F, J and N) as well as SOX2 and 
HDAC2 overlay at 40x (G, K and O) and 60x magnifications (H, L and P). 
Higher magnification views are shown in 60x magnification panels (insets H, 
L and P). Double-label indicates that HDAC1 is predominantly localized to 
the nuclei of optic nerve glia. Arrows indicate nuclei that are co–labeled and 
arrow heads are pointing cells that do not show co label. Peptide controls (Q, 
R and S) for all the three stages were run after pre absorption with the primary 
antibody to verify the specificity of the HDAC1 antibody. Scale bars: (B) Bar = 
50 µm for images B and C (E) Bar = 50 µm (E-G, I-K and M-O) (F) Bar = 50 µm 
for H, L and P.  
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Fig.34 Localization of HDAC2 in chick optic nerve: Low magnification view of 
the ES (A) and E18 (B) optic nerve, optic nerve head and retina is shown to 
aid in orientation of the sections. Pecten in image B represents the 
vascularized part of the chick retina. Confocal imaging of SOX2, HDAC2 and 
DAPI triple label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H 
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and I) and E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization of the optic nerve and optic nerve head (C, G and 
K). DAPI is not included in subsequent overlays as it appeared to obscure 
some of the immunolabel. HDAC2 only label is shown (D, H and L) as well as 
SOX2 and HDAC2 overlay at 40x (E, I and M) and 60x magnifications (F, J 
and N). Higher magnification views are shown in 60x magnification panels 
(insets F, J and N). Double-label indicates that HDAC2 is localized to the 
nuclei of optic nerve glia. Arrows indicate nuclei that are co–labeled and 
arrow heads are pointing to the cells that do not show co label. Peptide 
controls (O, P and Q) for all the three stages were run after pre absorption with 
the primary antibody to verify the specificity of the HDAC2 antibody. Scale bars: 
(A) Bar = 50 µm for A and B (C) Bar = 50 µm for panels C-E, G-I and K-M (F) 
Bar = 50 µm for F, J and N.   
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Fig.35 Localization of HDAC3 in chick optic nerve: Low magnification view of 
the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown to aid 
in orientation of the sections. Pecten in image B represents the vascularized 
part of  the chick retina. Confocal imaging of SOX2, HDAC3 and DAPI triple 
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label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H and I) and 
E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown to aid in 
localization of the optic nerve and optic nerve head (C, G and K). DAPI is not 
included in subsequent overlays because it appeared to obscure some of the 
immunolabel. HDAC3 only label is shown (D, H and L) as well as SOX2 and 
HDAC3 overlay at 40x (E, I and M) and 60x magnifications (F, J and N). 
Higher magnification views are shown in 60x magnification panels (insets F, J 
and N). Double-label indicates that HDAC3 shows variable localization 
pattern. It is predominantly localized to the cytoplasm at E5 stage and to both 
nuclei and cytoplasm of optic nerve glia at E8 and E18 stages. Arrows 
indicate cells showing the localization pattern and arrow heads pointing to the 
cells that donot show co label. Peptide controls (O, P and Q) for all the three 
stages were run after pre absorption with the primary antibody to verify the 
specificity of the HDAC3 antibody. Scale bars: (A) Bar = 50 µm for images A 
and B (C) Bar = 50 µm for panels C-E, G-I and K-M (F) Bar = 50 µm for images 
F, J and N.  
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Fig.36 Localization of HDAC4 in chick optic nerve: Low magnification view of 
the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown to 
aid in orientation of the sections. Pecten in image B represents the 
vascularized part of the chick retina. Confocal imaging of SOX2, HDAC4 and 
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DAPI triple label of sections of chick optic nerve at E5 (C, D and E), E8 (G,H 
and I) and E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization of the optic nerve and optic nerve head (C, G and 
K). DAPI is not included in subsequent overlays because it appeared to 
obscure some of the immunolabel. HDAC4 only label is shown (D, H and L) 
as well as SOX2 and HDAC4 overlay at 40x (E, I and M) and 60x 
magnifications (F, J and N). Higher magnification views are shown in 60x 
magnification panels (insets F, J and N). Double-label indicates that HDAC4 
is localized to the nucleus and cytoplasm. Arrows indicate nuclei that are co–
labeled and arrow heads point towards the cells that do not show the co 
label. Peptide controls (O, P and Q) for all the three stages were run after pre 
absorption with the primary antibody to verify the specificity of the HDAC4 
antibody. Scale bars: (A) Bar = 50µm for images A and B (C) Bar = 50 µm for 
panels C-E, G-I and K-M (F) Bar = 50 µm for images F, J and N.  
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Fig.37 Localization of HDAC5 in chick optic nerve: Low magnification view of 
the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown to aid 
in orientation of the sections. Pecten in image B represents the vascularized 
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part of the chick retina. Confocal imaging of SOX2, HDAC5 and DAPI triple 
label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H and I) and 
E18 (K,L and M). Overlay of SOX2 (green) and DAPI (blue) is shown to aid in 
localization of the optic nerve and optic nerve head (C, G and K). DAPI is not 
included in subsequent overlays because it appeared to obscure some of the 
other immunolabel. HDAC5 only label is shown (D, H and L) as well as SOX2 
and HDAC5 overlay at 40x (E, I and M) and 60x magnifications (F, J and N). 
Higher magnification views are shown in 60x magnification panels (insets F,J 
and N). Double-label indicates that HDAC5 is localized to the nucleus and 
cytoplasm of optic nerve glia. Arrows indicate nuclei that are co-labeled and 
arrow heads are pointing cells that do not show co label. Peptide controls (O, 
P and Q) for all the three stages were run after pre absorption with the primary 
antibody to verify the specificity of the HDAC5 antibody. Scale bars: (A) Bar = 
50 µm for images A and B (C) Bar = 50 µm for panels C-E, G-I and K-M (F) Bar 
= 50 µm for images F, J and N.  
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Fig.38 Localization of HDAC6 in chick optic nerve: Low magnification view of 
the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown to 
aid in orientation of the sections. Pecten in image B represents the 
vascularized part of the chick retina. Confocal imaging of SOX2, HDAC6 and 
DAPI triple label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H 
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and I) and E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization of the optic nerve and optic nerve head (C, G and 
K). DAPI is not included in subsequent overlays because it appeared to 
obscure some of the other immunolabel. HDAC6 only label is shown (D, H 
and L) as well as SOX2 and HDAC8 overlay at 40x (E, I and M) and 60x 
magnifications (F, J and N). Higher magnification views are shown in 60x 
magnification panels (insets F, J and N). Double-label indicates that HDAC8 
is localized to the nucleus and cytoplasm of optic nerve glia. Arrows indicate 
nuclei that are co–labeled and arrow heads are pointing to cells that do not 
show co label. Peptide controls (O, P and Q) for all the three stages were run 
after pre absorption with the primary antibody to verify the specificity of the 
HDAC8 antibody. Scale bars: (A) Bar = 50 µm for images A and B (C) Bar = 50 
µm for panels C-E, G-I and K-M (F) Bar = 50 µm for images F, J and N.  
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Fig.39 Localization of HDAC8 in chick optic nerve: Low magnification view of 
the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown to aid 
in orientation of the sections. Pecten in image B represents the vascularized 
part of the chick retina. Confocal imaging of SOX2, HDAC8 and DAPI triple 
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label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H and I) and 
E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is shown to aid in 
localization of the optic nerve and optic nerve head (C, G and K). DAPI is not 
included in subsequent overlays because it appeared to obscure some of the 
other immunolabel. HDAC8 only label is shown (D, H and L) as well as SOX2 
and HDAC8 overlay at 40x (E, I and M) and 60x magnifications (F, J and N). 
Higher magnification views are shown in 60x magnification panels (insets F, J 
and N). Double-label indicates that HDAC8 is localized to the nucleus and 
cytoplasm of optic nerve glia. Arrows indicate nuclei that are co–labeled and 
arrow heads are pointing to cells that do not show co label. Peptide controls 
(O, P and Q) for all the three stages were run after pre absorption with the 
primary antibody to verify the specificity of the HDAC8 antibody. Scale bars: (A) 
Bar = 50µm for images A and B (C) Bar = 50µm for panels C-E, G-I and K-M 
(F) Bar = 50µm for images F, J and N.  
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Fig.40 Localization of HDAC9 in chick optic nerve: Low magnification view of 
the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown to 
aid in orientation of the sections. Pecten in image B represents the 
vascularised part of the chick retina. Confocal imaging of SOX2, HDAC9 and 
DAPI triple label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H 
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and I) and E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization of the optic nerve and optic nerve head (C, G and 
K). Pecten in image B represents the vascularisedpart of the chick retina. 
DAPI is not included in subsequent overlays because it appeared to obscure 
some of the immunolabel. HDAC9 only label is shown (D, H and L) as well as 
SOX2 and HDAC8 overlay at 40x (E, I and M) and 60x magnifications (F, J 
and N). Higher magnification views are shown in 60x magnification panels 
(insets F, J and N). Double-label indicates that HDAC9 localized 
predominantly to the cytoplasm of optic nerve glia. Arrows indicate nuclei that 
are co–labeled whereas the arrowheads are pointing to the cells that do not 
show co label. Peptide controls (O, P and Q) for all the three stages were run 
after pre absorption with the primary antibody to verify the specificity of the 
HDAC9 antibody. Scale bars: (A) Bar = 50µm for images A and B (C) Bar = 
50µm for panels C-E, G-I and K-M (F) Bar = 50µm for images F, J and N.  
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Fig.41 Localization of HDAC10 in chick optic nerve: Low magnification view 
of the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown 
to aid in orientation of the sections. Pecten in image B represents the 
vascularised Part of the chick retina. Confocal imaging of SOX2, HDAC10 and 
DAPI triple label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H 
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and I) and E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization of the optic nerve and optic nerve head (C, G and 
K). DAPI is not included in subsequent overlays because it appeared to 
obscure some of the immunolabel. HDAC10 only label is shown (D, H and L) 
as well as SOX2 and HDAC10 overlay at 40x (E, I and M) and 60x 
magnifications (F, J and N). Higher magnification views are shown in 60x 
magnification panels (insets F, J and N). Double-label indicates that HDAC10 
has variable pattern of localization. It is present in the cytoplasm of optic 
nerve glia at E5 stage and is localized to nucleus and cytoplasm at E8 and 
E18 stage. Arrows indicate cells that show the pattern of localization and 
arrow heads are pointing to cells that do not show co label. Peptide controls 
(O, P and Q) for all the three stages were run after pre absorption with the 
primary antibody to verify the specificity of the HDAC10 antibody. Scale bars: 
(A) Bar = 50 µm for images A and B (C) Bar = 50 µm for panels C-E, G-I and K-
M (F) Bar = 50 µm for images F, J and N.  
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Fig.42 Localization of HDAC11 in chick optic nerve: Low magnification view 
of the E8 (A) and E18 (B) optic nerve, optic nerve head and retina is shown to 
aid in orientation of the sections. Pecten in image B represents the 
vascularized part of the chick retina. Confocal imaging of SOX2, HDAC11 and 
DAPI triple label of sections of chick optic nerve at E5 (C, D and E), E8 (G, H 
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and I) and E18 (K, L and M). Overlay of SOX2 (green) and DAPI (blue) is 
shown to aid in localization  of the optic nerve and optic nerve head (C, G and 
K). Pecten in image B represents the vascularized part of the chick retina. 
DAPI is not included in subsequent overlays because it appeared to obscure 
some of the immunolabel. HDAC11 only label is shown (D, H and L) as well 
as SOX2 and HDAC11 overlay at 40x (E, I and M) and 60x magnifications (F, 
J and N). Higher magnification views are shown in 60x magnification panels 
(insets F, J and N). Double-label indicates that HDAC11 is localized to the 
nucleus and cytoplasm of optic nerve glia. Arrows indicate nuclei that are co–
labeled and arrow heads are pointing to cells that do not show co label. 
Peptide controls (O, P and Q) for all the three stages were run after pre 
absorption with the primary antibody to verify the specificity of the HDAC11 
antibody. Scale bars: (A) Bar = 50 µm for images A and B (C) Bar = 50 µm for 
panels C-E, G-I and K-M (F) Bar = 50 µm for images F, J and N.  
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Fig.43 Expression of markers for the glial cells in murine optic nerve: Confocal 
images of dissociated cells from mature optic nerve double labeled for NG2 (B) 
and A2B5 (C). For panels A-D arrow depicts the O2Aprecursors which are 
NG2 (+) and A2B5 (+). For panels E-H the merged image (H) shows 
polydendrocytes that are NG2 (+) and PDGFRα (+). Scale bar: (D) = 50 µm.  
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Fig.44 Quantitative analysis of the glial precursors in the adult murine  optic 
nerve: The quantitation of the labeled cells revealed that all the cell types 
were present. The glial cell precursors predominantly present were O2A 
precursors (23%), astrocyte precursors/GRPs were found to be lowest in 
numbers(6%). 29% of the cells did not show label with any of the markers 
used for glial precursors.  
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Fig.45 Expression of markers for the glial cells in chick optic nerve: Confocal 
images of dissociated cells from E18 chick optic nerve double labeled for 
NG2 (B) and A2B5 (C), PDGFRα (F) and NG2 (G). For the panels A-D 
merged image (D) shows the cell that is an O2A progenitor which is NG2 (+) 
and A2B5 (+). For the panels E-H, the merged image (H) shows 
polydendrocytes that are NG2 (+) and PDGFRα (+). Scale bar: (D) = 50 µm.  
134  
 
 
 
Fig.46 Quantitative analysis of the glial precursors in E18 chick optic nerve: 
The quantitation of the labeled cells revealed that all the cell types were 
present. The glial cell precursors predominantly present were O2A precursors 
(18.7%), astrocyte precursors/GRPs were found to be lowest in 
numbers(5%). 56% of the cells did not show label with any of the markers 
used for glial precursors. 
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